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Can racial disparities in birth outcomes be partially attributed to 
stress? A Mendelian randomization study 
  
SPECIFIC AIMS 
Infant mortality rates are consistently higher in the United States (US) than in Europe and 
in other high income peer nations.1 This mortality disadvantage is driven by poor birth outcomes 
such as low birth weight (LBW) defined as weighing 2,499 grams or less at birth.2 LBW has 
many potential causes – one of the causes gaining attention is exposure to maternal stress. Many 
studies have found a positive association of stress exposure with LBW.3-7 These previous studies 
have limitations, however, which may limit the validity of their findings. Extant literature relies 
on observational case-control and cohort studies, which may be subject to residual confounding. 
Furthermore, the majority of these studies have relied on self-reported measures of stress, which 
may be susceptible to recall bias, or may lead to misclassification due to differential perceptions 
of stress.8  
To address this reliance on observational studies I will apply a quasi-experimental 
method capable of estimating causal associations, under a different set of assumptions than 
traditional observational studies, without investigator assigned random assignment. There are 
three main pathways through which the body responds to stress: a neuroendocrine pathway, a 
maternal vascular disease pathway, and an immune-inflammatory pathway. I will use mendelian 
randomization (MR), a technique that applies measured variation in genetic variants, ideally of 
known function, to examine the causal effect of a modifiable exposure on disease in 
observational studies,9 to determine whether these stress pathways are causally linked to LBW. 
A deeper understanding of these relationships will allow for better targeting of interventions to 
reduce poor birth outcomes. 
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Aim 1: Does mother’s neuroendocrine stress marker levels (e.g., cortisol) cause low birth weight 
using mendelian randomization? 
Aim 2: Does mother’s vascular reactivity (e.g., blood pressure) cause low birth weight using 
mendelian randomization?  
Aim 3: Does mother’s immunosuppression (e.g., white blood cell count) cause low birth weight 
using mendelian randomization? 
 
BACKGROUND AND SIGNIFICANCE 
 
In the US, LBW is a leading cause of infant death overall, and the leading cause of death 
for Black infants.2 This poor birth outcome may have serious implications not only for infant 
survival, but also for childhood growth and development and some important health outcomes in 
adulthood. It is difficult to determine the true effects of LBW on later outcomes because LBW 
could also be caused by a range of socio-economic characteristics of families, but LBW is 
associated with cognitive deficits,10 poorer language,11 and lower academic achievement,12 and 
need for special education.13 LBW babies may also be less likely to graduate from high school 
than are those who were full term.14 Furthermore, poor birth outcomes may be associated with 
increased health risks in adulthood15 including for cardiovascular disease,16 hypertension,17 and 
non-insulin dependent diabetes mellitus.17 
Understanding and preventing adverse birth outcomes is a major public health priority in 
the US. The primary cause of low birth weight is preterm birth.18 The clinical causes of preterm 
birth are fairly well understood. In some cases, preterm delivery is indicated because of 
artificially conceived multiple pregnancies, pre-eclampsia or eclampsia, and intrauterine growth 
restriction.19 Some births lead to spontaneous preterm births resulting from multiple causes, 
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including infection or inflammation, vascular disease, and uterine overdistension.19 Other risk 
factors for preterm birth and low birth weight include a previous preterm birth, periodontal 
disease, and low maternal body-mass index.19 Finally, though not understood quite as well, there 
is consensus that social factors such as social class, income, and race are also drivers of preterm 
birth and LBW.19,20 
I am particularly interested in understanding the role that race places in determining birth 
outcomes in the US. Race includes phenotypic characteristics such as skin color, 
whereas ethnicity also encompasses cultural factors such as nationality, tribal affiliation, 
religion, language and traditions of a particular group. For the purposes of this study, I will be 
focusing on race independent of ethnicity. Black women in the US are more likely to give birth 
to preterm and low birth-weight infants than their white counterparts.21 One of the most 
prominent explanations for the disparity seen in birth outcomes between Black and non-Hispanic 
white is socioeconomic and behavioral differences during pregnancy. Poverty, limited education, 
less opportunity for optimal health behaviors, and poor access to health care are important 
factors associated with adverse health outcomes.22 Black women disproportionately experience 
social disadvantages, such as single parenthood and poverty, compared with non-Hispanic white 
women in the US.23 However, research suggests that while differences in socioeconomic status 
and behavior might partially explain these differences in birth outcomes, these unfavorable 
conditions do not fully explain the birth outcome disparity between Black and non-Hispanic 
whites. 
In fact, this disparity persists even when controlling for a series of social, economic, and 
behavioral factors, including income, maternal age, parity, marital status, smoking, alcohol use, 
and health insurance coverage.24 For example, one study examined using a case-control study of 
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very low birth weight infants found that without controlling for any variables, the odds ratio 
(OR) for very low birth weight among Black women compared to non-Hispanic white women 
was 3.7, but even after controlling for age, education, occupation, drug, alcohol, and tobacco use, 
financial support from the child's father, income, marital status, and grandparent's education, the 
OR remained 3.3.25 Another study looked at racial differences in birth weight in extremely low-
risk US samples, meaning women who were married, with an age of 20–34 years, and having 
more than 13 years of education, at least one successful pregnancy, average number of children 
for maternal age, adequate prenatal care, vaginal delivery, and no reports of medical risk factors, 
tobacco use, or alcohol use during pregnancy. The study found that Black mothers had 2.64 
(95% CI 2.51, 2.78) times a greater risk of having a baby with low birth weight as compared to 
non-Hispanic White mothers.26 In addition, limitations to this hypothesis have been 
demonstrated through studies conducted among enlisted soldiers living on military bases. 
Families living on military bases have virtually the same income, access to health care, and 
living conditions, regardless of race, and yet disparities in gestational age and birth weight 
persist.26 In summary, a variety of studies suggest that the socioeconomic and behavioral 
explanations for higher risk of LBW among Blacks compared to whites in the US are limited. 
After accounting for income, maternal age, education, substance use, prenatal care, and 
educational status, the disparity in adverse birth outcomes continues to be approximately twofold 
or greater.27 
Increasingly experts seem to agree that disparities in birth outcomes are rooted in racism. 
Structural racism in health care and social service delivery means that Black women often 
receive poorer quality care than white women.28,29 Additionally, it is well understood that the 
cumulative experience of racism triggers a chain of biological stress processes, known as 
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weathering, that undermine Black women’s physical and mental health.30 Numerous case-control 
and cohort studies have demonstrated an association of exposure to general and pregnancy 
related stress with LBW.5-7,31,32 Furthermore, studies have shown that pregnant women of color 
in the US experience greater levels of stress overall, as well as additional sources of stress due to 
experiences of discrimination and racism, which could partially explain racial disparities in rates 
of LBW.4,33-35 
In the absence of a direct measure of stress exposure or weathering, the concept of 
allostatic load, or the cumulative wear and tear on the body’s systems owing to repeated 
adaptation to stressors was created.36-38 Allostatic load is considered the physiological burden 
imposed by stress. High allostatic load is associated with higher rates of mortality, incidence of 
cardiovascular disease, and decline in cognitive and physical functioning.39 The allostatic load 
algorithm reflects the fact that the human stress response disrupts regulation of various systems 
throughout the body, the neuroendocrine, cardiovascular, and immune systems.37 Though one 
could choose to look at the effects of allostatic load more broadly on birth outcomes, it seems 
worthwhile to also explore the effects of each individual pathway.  A growing body of research, 
largely driven by Dr. Pathik Wadhwa, has built support for neuroendocrine, immune, and 
vascular mechanisms of preterm birth.40,41 However, by Dr. Pathik’s own admission, very little 
empirical research to date has examined the role of biological processes as mediators of the 
relationship of stress with preterm birth or low birth weight.40 
There is some evidence suggesting that cortisol, the primary stress hormone, is associated 
with LBW,42-45 and thus might be a mechanism through which stress affects birth outcomes. 
Within the neuroendocrine system, corticotropin stimulates secretion of cortisol by the adrenal 
cortex in response to stressors. Elevated cortisol inhibits release of corticotropin by the anterior 
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pituitary gland and inhibits release of corticotrophin releasing hormone (CRH) by the 
hypothalamus. Chronic emotional or physical stress can interrupt this negative feedback loop, 
resulting in an overproduction of cortisol46 - making cortisol a good metric for measuring stress. 
Maternal stress has been shown to be associated with increases in placental, decidual, and 
amniochorionic expression of CRH.40 In vivo studies have found significant correlations among 
maternal pituitary–adrenal stress hormones such as cortisol and placental CRH levels.47-50 CRH 
acts directly on the uterus and cervix and interacts with both prostaglandins and oxytocin, the 
two major uterotonics that mediate the stimulation and maintenance of myometrial contractility 
at term and during labor.51 Thus a potential mechanism may be that stress leads to elevated 
cortisol levels, which cause unregulated CRH levels, and in turn poor birth outcomes. 
Women who experience heightened vascular reactivity may also be at increased risk of 
low birth weight. Many observational studies have suggested that maternal BP is associated with 
offspring birth weight.52-70 However, these studies may be subject to residual confounding due to 
common causes of exposure and outcome such as socioeconomic position that were not 
comprehensively considered or that were not adjusted for, given the difficulty of capturing all 
aspects of such attributes. Several quasi-experimental MR studies, less open to confounding, 
have also demonstrated a relationship of higher maternal BP with lower offspring birth weight.71-
73 These findings, however, are limited by small sample size, use of data pertaining to both men 
and women, lack of adjustment for the effects of fetal genetics on birth weight, or focus limited 
to the independent effects of systolic and diastolic blood pressure, when these are related 
exposures. 
Additionally, preliminary research suggests that perhaps maternal stress and infection 
work in concert to cause poor birth outcomes. In a cross-sectional investigation of a sample of 72 
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pregnant women, Herrera et al. reported that high levels of maternal psychological stress and low 
levels of social support were associated with lower lymphocyte activity.74 Furthermore, greater 
stress during pregnancy is associated with urogenital infections,75 which increases women’s risk 
for LBW.76 Microbial colonization and inflammation in the maternal genital tract has emerged as 
a major risk factor for spontaneous preterm birth.77 Leukocytes participate in the maintenance of 
pregnancy and alteration in their function or abundance may lead to labor at term or preterm.78 
Neutrophil and eosinophil infiltration of the uteroplacental tissues and amniotic fluid have been 
associated with preterm labor.79-81 The most prevalent lower genital tract infection in women of 
reproductive age, bacterial vaginosis (BV), is associated with a higher risk of LBW and preterm 
labor.82-84 In addition, as an additional means of assessing effects of immune function, I also 
examined the associations with birth weight of two important aspects of immune function, 
corresponding to the cytokines interleukin-6 (IL6)85 and interleukin 1 receptor antagonism 
(IL1ra). These cytokines are also targeted by well-established anti-inflammatory drugs, i.e., 
tocilizumab and anakinra.86 
These findings suggest that the neuroendocrine, vascular, and immune pathways may 
each contribute to LBW, but there is still much to be learned. Observational studies have been 
immensely valuable in the field of public health; some of the most notable victories include 
identifying the role of smoking in health,87,88 the role of folic acid in pregnancy,89-91 and the 
benefits of babies sleeping on their backs.92 However, there have been some notable failures with 
observational studies leading to biased estimates and spurious findings,93,94 for example as 
regards diet. Extant literature on maternal stress and birth outcomes relies primarily on 
observational case-control and cohort studies. The internal validity of these studies may be 
threatened by residual confounding. For example, BMI95,96 and smoking97,98 are both causes of 
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cortisol and BP as well as infant birth weight. Incomplete control for these confounders could 
lead to biased findings. Lack of control for additional confounders that may be unknown or for 
which data may not exist could further bias findings. It is also possible that the management of 
pregnancy may induce stress, for example learning that a growing fetus is expected to be born 
underweight may cause maternal stress. Furthermore, the majority of studies have relied on self-
reported measures of stress, which may be susceptible to recall bias and systematic error or may 
lead to misclassification due to differential perceptions of stress.99 
Unbiased estimates may be derived from randomized control trials (RCTs), but these are 
not always feasible. For example, in this case it would be unethical to randomize pregnant 
women to stressful conditions, and logistically taxing to construct low stress conditions for 
women during pregnancy. In lieu of RCTs, quasi-experimental studies, including instrumental 
variable designs such as MR, are viable alternatives.100 MR uses naturally occurring differences 
in genetic make-up to reduce residual confounding, and produce unconfounded estimates that 
allow us to draw causal inferences about the effects of maternal stress exposure on LBW.101  
 More rigorous studies of the association of maternal stress with LBW are vital to help 
determine causes of poor birth outcomes. If we could better understand the effects of maternal 
stress on LBW, we might better understand racial disparities in birth outcomes. Thus, I propose 
to perform a large-scale MR study to comprehensively investigate the causal effects of maternal 
stress biomarkers (e.g., cortisol, blood pressure, white blood cell count) on birth weight. MR 
provides a means of obtaining unconfounded estimates from observational studies when all 
assumptions are met. Using this study design, which is subject to different types of biases and 
assumptions than the existing literature on this topic, will complement previous studies and help 




The proposed study is innovative in that it would be among the first of its kind to study the 
effects of indicators of responses to stress on LBW using an MR study design. Previous studies 
on this topic have primarily relied on large observational case-control and cohort studies that are 
open to confounding and selection bias. In turn, these threats to internal validity may have led to 
biased estimates. Applying a quasi-experimental design reduces residual confounding, that allow 
us to have more confidence in drawing causal inferences for effects of maternal stress exposure 
on LBW, albeit cognizant that MR is open to selection bias. Although MR is subject to different 
types of biases and assumptions, it complements existing studies. If the results of this MR 
analysis support previous studies, it gives more confidence in these findings. Furthermore, this 
study would be one of the first to use MR to explore birth outcomes, opening the door to new 




It has long been understood that exposures in utero and during childhood have profound 
effects on long-term health and development.102-104 In 1995 David Barker wrote: “The fetal 
origins hypothesis states that fetal undernutrition in middle to late gestation, which leads to 
disproportionate fetal growth, programs later coronary heart disease.”105 Dr. Barker generated 
what has since become a much larger discussion about the importance of exposure events before 
birth for fetal development and lifetime health. Many studies show that specifically exposure to 
maternal stress during pregnancy poses an increased risk for her child to have a wide range of 
adverse outcomes as discussed above, including LBW. The general idea is that mothers are 
exposed to many different stressors. This may include, for example, major life events, pregnancy 
anxiety, socio-demographic factors, violence and abuse, and racism and discrimination.4-6,32,33,106 
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Exposure to these stressors leads to the experience of maternal stress. In turn, mothers then 
experience physiologic responses to this experience of stress, including a neuroendocrine 
response (cortisol released into the blood stream), a vascular response (maternal blood pressure 
increase) and an immune response (maternal immunity). Each of these responses, or any 
combination of three will lead to LBW. This conceptual framework is depicted in Figure 1.1. 
 
Study Design  
This study will use a MR design. MR is an instrumental variable analysis (IVA) using 
genetic variants as instruments. IVA can be used to estimate causal relationships before 
controlled experiments or when they are not feasible. Instrumental variables must satisfy three 
core assumptions: the instrument cannot be associated with potential confounders of the 
relationship between exposure and outcome, the instrument should not affect the outcome 
through a pathway other than affecting the exposure (also known as the exclusion restriction 
assumption), and the instrument must be associated with the exposure, although obviously not 
identical or it would be subject to the same biases.107 
Most commonly single-nucleotide polymorphisms (SNPs) are employed as instruments 
when conducting an MR analysis. In this study I propose to use maternal genetics as instruments 
for the exposures to ascertain how they are related to poor birth outcomes free from confounding. 
There is, however, concern that maternal genetics might lead to poor birth outcomes through 
fetal genetics, which would violate the exclusion restriction assumption, so this has been 
addressed by using information from a study that implemented structural equation modeling to 
isolate infant genetics from maternal genetics. The proposed directed acyclic graph (DAG) for 





This study will use data from several sources and thus will include several populations. Genetic 
associations of maternal genetic effects on birth weight were extracted from the Early Growth 
Genetics Consortium (EGGC) genome-wide association study (GWAS) of birth weight. Genetic 
associations representing mother's genetic effect on offspring birth weight, after adjusting for 
offspring's genotype,72 are the genotype most closely corresponding to maternal exposures 
during pregnancy. The EGGC GWAS included 264,498 women of European descent, 179,360 
for whom offspring birth weight was also available, given not all have offspring, from the EGGC 
and the UK Biobank data (released May 2017). The 12 studies from the EGGC conducted 
genome-wide association analysis of z-score transformed offspring birth weight adjusted for sex, 
gestational duration and ancestry informative principal components where necessary. The UK 
Biobank included 502,655 participants.108 Of the 273,467 women, 216,839 reported the birth 
weight of their first child at one assessment center visit, bearing in mind that not all women bear 
children. Respondent	reported	birth	weight	is	considered	a	reliable	alternative	to	chart	
obtained	birth	weight.109	Values were recorded to the nearest whole pound, and converted to 
kilograms. Where women reported the birth weight of the first child at multiple time points these 
were averaged and women were excluded if the mean difference between any 2 offspring BW 
measurements was >1kg (N=31). Women who reported BW of their first child <2.2kg or >4.6kg 
were also excluded (N=6,333). Genetic estimates in EGGC were imputed to the 1000 Genomes 
Project (Phase 1 v3) reference panel and in the UK Biobank were imputed to the HRC reference 
panel.72 Genetic associations with maternally determined birth weight were obtained using linear 
regression in the EGG consortium and a linear mixed model in the UK Biobank, with adjustment 
for gestational age, where available, and study specific covariates, such as non-confounders that 
might add variability and thereby impact precision, including batch and genetic analysis chip.72 
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Warrington et al. used a  structural equation modeling (SEM) approach to estimate maternal and 
fetal effects independent of the fetal and maternal genotype respectively including the observed 
participant’s genotype, their own self-reported BW, and the BW of their first child, and two 
latent (unobserved) variables, for the genotype of the participant’s mother and for the genotype 
of the participant’s offspring.72 	
 
Exposures 
Published genetic predictors of morning plasma cortisol were obtained from Crawford et 
al. (2019)110 based on a genome wide association study (GWAS) of morning plasma cortisol 
conducted by the CORtisol NETwork (CORNET) consortium (n=12,597) largely in people of 
European descent. Sex-specific genetic associations with blood pressure and leukocyte count 
were extracted from the UK Biobank genetic summary statistics for women only. The UK 
Biobank is one of the largest biobanks globally. It recruited over 500,000 participants (intended 
to be aged 40–69 years) in England, Scotland and Wales from 2006 to 2010. Participants 
completed a questionnaire and a comprehensive assessment at baseline, genotyping, and 
longitudinal follow-up via record linkage to medical and mortality records is ongoing, as 
described in detail elsewhere.111-113 Genotyping was performed using two very similar arrays, 
including Affymetrix UK BiLEVE, Axiom array, and Affymetrix UK Biobank Axiom array. 
Further information on the genotyping process is available on the UK Biobank website 
(http://www.ukbiobank.ac.uk/scientists-3/genetic-data).114 Summary sex-specific genetic 
associations adjusted for age, age2, and the first 20 principal components are publicly available 
(http://www.nealelab.is/uk-biobank) and were used to obtain genetic instruments for the 
exposures. 
 
Data Sources, collection and management  
 20 
All data used for this research are previously collected and were obtained from existing 
GWAS or the UK Biobank. No data collection or management of any kind took place. All data w 
de-identified and can simply be pulled from peer-reviewed articles or downloaded from websites 
without the need to establish a data use agreement (DUA). All datasets have implemented 
genomic control by adjusting for principal components in kinship matrices in an attempt to 
eliminate confounding due to population stratification. Below is a description of the data sources 
used here. 
 
1. To provide genetic associations with birth weight the EGG Consortium (2019) was 
utilized for each of the three aims. It contains mother's genetic effect on offspring birth weight, 
after adjusting for offspring's genotype, sex, gestational duration, and ancestry informative 
principal components. Birth weight was selected as an outcome primarily because no such 
GWAS exists for gestational age. However, it also in part because birth weight is more reliably 
measured than gestational age.115 Although, low birth weight is conceptually distinct from 
preterm birth, the two concepts overlap. Among low-birth-weight infants, approximately two-
thirds are born preterm.115 Birth weight was thus also selected as my outcome measure because it 
captures a larger swath of newborns. Regardless of whether a baby is born preterm, research 
shows that the lower the baby’s birth weight, the greater the risk for complications.116 As 
gestational age is not a cause of maternal stress, and in fact is more likely a result of maternal 
stress, gestational age is probably a mediator of the relationship of maternal stress with LBW, 
rather than a confounder. In addition, adjusting for heritable covariates, i.e., consequences of 
genetic make-up, can bias estimates in genome-wide association studies.117 I therefore am not 
sure gestational age should have been adjusted for, but am limited to using the data currently 
available, which does not adjust for gestational age. Other covariates, such as maternal age, have 
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also not been adjusted for but again are not always common causes of maternal genetics and 
LBW. 
   
2. To provide genetic predictors of cortisol for aim 1 (Crawford et al. (2019)) was used. 
Morning plasma cortisol was collected from participants between 700 and 1100 AM and was 
operationalized as a continuous variable and analyzed as such. Cortisol comes from blood 
samples supplied by study participants that were then analyzed for concentration of metabolic 
byproducts. 
 
3. To provide sex-specific genetic predictors of blood pressure for aim 2 UK biobank 
data was used. Blood pressure was assessed using digital blood pressure monitors (HEM-
7015IT; Omron Healthcare Inc) during the initial assessment visit (2006-2010). The average of 
two blood pressure measurements taken at least 1-minute apart was used. Participants were 
classified as having hypertension if systolic BP ≥140 mmHg, diastolic BP ≥90 mmHg, self-
reported use of antihypertensive medication, or self-reported doctor-diagnosed hypertension. 
Genetic associations with BP were not adjusted for medication use, because it is more likely to 
be a consequence than a cause of genetic make-up. 
 
4. To provide sex-specific genetic predictors of white blood cell counts for aim 3 the UK 
biobank was used. WBC counts were measured on fresh samples as an absolute number per unit 
volume, and their component leukocytes (lymphocytes, monocytes, neutrophils, eosinophils, and 
basophils) as absolute measures and proportions of the overall white blood cells. Complete blood 
cell counts (cells/L) were measured using a Coulter LH 750 System (Beckman Coulter, Brea, 
CA) as per manufacturer’s procedures.  To provide genetic predictors of IL6 and IL1ra, well-
established variants were used.85,86 
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An application for this research was submitted to the Human Research Protections 
Program Office of the Graduate School of Public Health and Health Policy (GSPHHP) at the 
City University of New York (CUNY), which included a detailed study protocol. This 
application was submitted as “Exempt Human Subjects Research”. This Human Subjects 
Research falls under Exemption 4 because the research uses data from the UK Biobank, which 
means that is will rely on existing data that is publicly available and which is recorded in such a 
manner that subjects cannot be identified, directly or through identifiers linked to the subjects. 
 
Data analysis plan (applies to each aim) 
 
The first step of MR analysis is to evaluate that the core assumptions are being met. The 
first assumption, the relevance assumption - that an association exists of instrument on exposure 
- can be tested by using a rigorous p-value, i.e., genome wide significance. Smith et al. for 
example used the genome wide significant p value of 5 x 10^-8.118 Given, correlated genetic 
predictors of the exposures may exist, i.e., (due to linkage disequilibrium) independent predictors 
of each exposure (r2<0.001) was obtained using ld_clump from MRbase 
(https://mrcieu.github.io/ieugwasr/reference/ld_clump.html). The second (independence) and 
third (exclusion-restriction) assumptions are not empirically verifiable. However, one can test 
whether any instruments are associated with confounders using Phenoscanner 
(http://www.phenoscanner.medschl.cam.ac.uk) or MR-Base Phewas 
(https://gwas.mrcieu.ac.uk/phewas/) that have comprehensively curated associations of SNPs 
with many phenotypes and so provide potential associations of the SNPs used with specific 
confounders. Many researchers consider that this assumption is met simply because of the 
random allocation of alleles to gametes.101 The third assumption can be tested by assessing 
whether there is a known association of the SNPs used as genetic instruments (and the gene on 
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which it is located) with the outcome of interest other than via the exposure, i.e., the instruments 
are free from pleiotropic effects, again using curated genotype to phenotype cross references. 
Despite the stringent assumptions of MR studies, the violation of which may cause bias, this 
study design has been able to replicate findings from RCTs.119,120 
Once assumptions have been tested, the actual analysis can be carried out. The causal 
effect of the exposure (X) on the outcome (Y) via the instrument (G) can then be estimated by: 
 ,  
where  (i.e., a Wald estimate) represents the causal effect estimate obtained 
from  and , the regression coefficients obtained from the regression of the outcome 
on the genetic instrumental variable and the regression of the exposure on the genetic instrument 
respectively.121 This approach is equivalent to the commonly used two-stage least squares 
approach used in instrumental variable analysis.107,122 The process of generating regression 
coefficients for  and  can be done using the same study, or can be done using 
multiple studies if necessary, meaning using one study to obtain genetic variants on exposure, 
and another study to obtain genetic variants on outcome.123,124 There are advantages to a two-
sample MR study such as increased statistical power and decreased risk of bias due to weak 
instruments or “winner’s curse”. However, two-sample MR studies are also limited in their 
ability to support sub-group analyses, to test for non-linear effects, and to test whether the risk 
factor-outcome association is related to the genetic instruments.125 
If multiple genetic instruments are used, multiple Wald estimators need to be summarized. One 
popular method is to meta-analyze the Wald estimates together using inverse variance weighting 
(IVW) with an approximation for the variance. One may also consider conducting sensitivity 
analysis to check the validity of the meta-analyzed Wald estimator. This can be done using a 
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weighted median approach, which assumes that ‘instruments’ representing over 50% of the 
weight are valid instrumental variables, or MR Egger method, which is able to assess whether 
genetic variants have pleiotropic effects on the outcome that differ on average from zero.126,127 I 
will consider applying MR-Presso and MR-RAPs, which each have the advantage of addressing 
possible pleiotropy and giving a revised estimate.128,129 Finally, I used the contamination mixture 
model (conmix) which has a contrasting plurality valid assumption and may be the best method, 
judged by mean squared error.130 These processes were carried out for each aim. This means that 
for each aim, the three specific assumptions of MR were tested, genetic associations with birth 
weight were extracted for SNPs predicting each stress marker, Wald estimates were meta-
analyzed together using inverse variance weighting with random effects, and sensitivity analysis 
were conducted using MR Egger, the weighted median, conmix and other methods as 
appropriate. Some multivariable analyses were also conducted where exposures were thought to 
be correlated, so as to obtain independent effects of each exposure. All analyses conducted using 
R version 4.0.2 (R Foundation for Statistical Computing, Vienna, Austria), and the 
“MendelianRandomization”, “TwoSampleMR”, and “MVMR” packages.  
 
 
Statistical power and sample size 




where b is the effect size, α is the desired significance level of the test (conventionally 
0.05), Φ is the cumulative distribution function of the standard normal distribution, zδ is the 
value which satisfies  and  ⁠, the ratio of the sample variance in Y due to factors 
other than X to the sample variance of X.131 
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Essentially the power for a MR study depends on the proportion of the variance explained 
by the genetic instruments and the sample size for the outcome, because the sample size required 
for a MR study can be approximated by the sample size for exposure on outcome divided by the 
variance explained for genetic instruments on exposure.131 In general, MR studies need large 
samples. The data sources that I used have a large sample size and thus were well powered to 
detect associations between physiological markers of stress and low birth weight. The strength of 
the genetic instruments was obtained from the F-statistic, obtained using an approximation.127 
 
A. Generalizability and Transportability 
MR studies should be free of confounding by design. MR studies are open to selection 
bias, because of the gap between randomization at conception and recruitment in later life. 
However, there is no particular reason to think that people in any of the studies used have been 
recruited based on their genetic propensity to stress and their birth weight, even because of 
selective survival. As such, MR studies can have high internal validity.  One must consider, 
however the possibility that stress could reduce fertility and lead to a greater likelihood of 
miscarriage among those who do get pregnant. 
External validity, as generalizability to the rest of the population from which the study 
sample came, depends on study design and the representativeness of the sample of the 
underlying population. The GWAS used in this study almost entirely relate to people of 
European descent, whereas the target population here encompasses a wider range of 
backgrounds. External validity, as transportability to new population, beyond the studied 
population, can be thought of depending on the relevance of the mechanism in a different 
population.132 This research is designed to test for a specific biological mechanism. It is 
commonly understood that biological pathways work consistently for most people, although they 
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could be less relevant in some groups than others. If I can understand the causal effects of 
physiological markers of stress on poor birth outcomes in this population, the findings can likely 
be extended to most populations.  
 
B. Limitations 
This study has some overarching limitations. First, I must consider potential for selection 
bias in that the validity of the findings of an MR study are dependent upon the integrity of the 
underlying GWAS. Those who participate in large scale genetic studies may be healthier than the 
general population, leading to a healthy volunteer effect.133 However, a healthy volunteer effect 
will only bias the findings if it creates an open pathway from genetic make-up to the exposures 
and outcomes of interest, for example if the participants were selected on genetics and blood 
pressure. Genetics could affect health and hence taking part in a study of healthy volunteers, 
such as the UK Biobank, effects of selecting on healthy survivors are probably most marked at 
older ages, particularly as fertility trades-off against survival. Conversely, it is possible that many 
considerations, including health status may have determined participation in studies used here, 
such as the UK Biobank. Additionally, genetic studies are open to bias from survival, which is 
compounded if common causes of survival and outcome exist.134 The GWAS I intend to use are 
in relatively young people, however, and study exposures that do not share many common causes 
with conditions that cause death at earlier ages making such selection bias less likely. In the case 
that selection bias does exist due to miscarriage, should those who are missing be women who 
experienced high stress and were going to have a small baby, then the study will be biased 
towards the null or even reversed. Due to data availability limitations the study contains only 
participants of European descent who may not even be mothers. Genetic studies that include 
many Americans or that can be subsetted to a black population either do not exist or are not sex-
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specific. Nonetheless, valid assessment of the relationship of maternal stress with offspring birth 
weight may not require participants to be representative of the population at large. Causes are 
generally expected to act consistently, but may not be relevant to all populations.135 As such, the 
findings are not only generalizable to white, European populations, but could also be 
transportable to non-European populations of color. In other words, I have no reason to believe 
that stress pathways would affect LBW differently in different geographical or racial 
populations. 
Next, I must consider the limitations related to the study design. MR, presents several 
challenges and limitations. First, an issue to consider is lack of power related to the modest 
effects of genotype for most complex phenotypes. It is recommended that to avoid this issue one 
use genotypes with reliably established association with exposures, meaning that they have been 
replicated in several independent studies, and ideally can be confirmed within the MR study.101 I 
attempted to do this whenever possible as given in the relevant chapters.  
One must also consider that unreliable study estimates can result from a number of 
genotyping errors, including poor quality or quantity of DNA, biochemical artifacts, faulty 
equipment and human error in reading outputs and entering data,136 which are usually excluded 
during quality control. Though I am unable to verify the quality of study data, whenever 
possible, I conducted sensitivity analyses using several different data sources to validate my 
findings. 
 Population stratification, differences in allele frequencies between subpopulations as a 
result of non-random mating between individuals, can occur when specific subgroups within the 
population experience different rates of diseases and have different frequencies of the alleles of 
interest. This can lead to genetic estimates biased by confounding of the associations of genotype 
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on disease in the study population.137 This may be of particular concern when the genetic 
associations for the exposure were obtained from a different study population than the genetic 
associations with the outcomes. In this study, however, bias from population stratification is 
unlikely because the samples largely from people of European descent with appropriate genomic 
control. 
Pleiotropy is another biological phenomenon of potential concern. Pleiotropy is the 
potential for genetic polymorphisms to have more than one specific phenotypic effect. If the 
genetic variant displays pleiotropic effects that directly influence the outcome of interest, then 
the exclusion-restriction assumption will be violated leading to biased findings. Sensitivity 
analyses using analytic methods designed to account for potential pleiotropy (e.g., MR-PRESSO) 
can help address this issue.  
Finally, canalization, or developmental compensation, should be considered as well. This 
refers to the buffering of the effects of either environmental or genetic forces attempting to 
perturb development.138 This buffering likely occurs through several mechanisms including 
genetic redundancy, feedback regulation and cooperative biochemical interactions.139 This 
phenomenon may invalidate findings from MR studies by changing the effect of genotype on the 
outcome of interest in adulthood without any effect of the association of genotype with the 
exposure of interest. This could mean an invalid estimate and a biased IV estimate of causal 
effect.  
Other limitations include the potential difficulty of interpreting the findings, specifically 
potential inability to assess the magnitude of causal associations. MR may also give us the effect 
of total endogenous exposure rather than stress specific exposures. For example, high blood 
pressure or immunosuppression could affect other underlying causes rather than stress. Finally, 
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new GWAS, such as a recent release by Crawford et al. which contained more participants and 
SNPs than their original analysis,140 continue to become available, which may lead to different 












Figure 1.2. Directed acyclic graph (DAG) considering relationship between maternal/fetal genetics 
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Can racial disparities in birth outcomes be partially attributed to 
stress: a Mendelian randomization study of cortisol as a cause of 




In the United States, low birth weight (LBW) is a leading cause of infant death overall, and the 
leading cause of death for Black infants. Understanding and preventing adverse birth outcomes is 
a major public health priority. Observationally, there is some evidence to support the hypothesis 
that plasma cortisol may be associated with LBW. To clarify the effect of cortisol exposure on 
LBW, we used separate-sample instrumental variable analysis with genetic instruments 
(Mendelian randomization) based on 3 single nucleotide polymorphisms (SNP), from a genome 
wide association study, strongly (p-value < 5 × 10−6) and independently associated with morning 
plasma cortisol. These SNPs were applied to a large, extensively genotyped study of birth weight 
conducted by the Early Growth Genetics Consortium (EGGC), which contains mother's genetic 
effect on offspring birth weight, after adjusting for the correlated offspring's genotype (n 
=179,360). SNP-specific Wald estimates were meta-analyzed to obtain inverse variance 
weighted and MR-Egger estimates, taking into account correlations between SNPs. Higher 
genetically instrumented plasma cortisol was associated with lower birth weight using inverse 
variance weighting and contamination mixture. Birth weight decreased by about 19 grams (0.057 
standard deviation (SD), beta = -.057 (95% confidence interval (CI) -0.103, -0.021) and 21 
grams (.06 SDs, beta = -.06 (95% confidence interval (CI) -.13, -.01) for every unit increase of 
log transformed effect size of plasma cortisol. More investigation is required into the role of 





In the United States (US), low birth weight (LBW), defined as weighing 2,499 grams or 
less at birth, is a leading cause of infant death, particularly affecting Black infants.2 LBW is 
inversely associated with cognition,10 language development,11 and academic achievement,12,14 
and with greater need for special education.13 Furthermore, poor birth outcomes may be 
associated with health risks in adulthood15 including of cardiovascular disease,16 hypertension,17 
and non-insulin dependent diabetes mellitus.141 However, LBW could also be the result of socio-
economic characteristics, and associated disadvantages, which also lead to these health 
outcomes. 
Understanding and preventing adverse birth outcomes is a major public health priority in 
the US. Numerous case-control and cohort studies have demonstrated an association of exposure 
to general and pregnancy related stress with LBW.5-7,31,32 Furthermore, studies have consistently 
shown that Black women experience greater levels of general stress and pregnancy-related 
stress.4,33 Additionally, Black women are more likely to experience stress due to racism and 
discrimination, which is associated with worse birth outcomes.34,35,142 Increased exposure to 
stress during pregnancy may begin to partially explain racial disparities in birth outcomes in the 
US.143,144 
Limited research has attempted to explore the effect of various intervention strategies on 
maternal stress and birth outcomes. Randomized control trials support that stress reduction 
techniques such as counseling,145,146 mindfulness and relaxation,147-149 and psychotherapy150,151 
can all significantly reduce stress and anxiety during pregnancy. There is also evidence from 
randomized control trials that social support as a form of stress reduction reduces the incidence 
 33 
of LBW.152,153 Hence, should this study indicate a causal relationship between stress and birth 
weight, there are meaningful interventions that could be implemented immediately.  
There is some evidence suggesting that cortisol, the primary stress hormone, is associated 
with LBW42-45 and thus might be a mechanism through which stress affects birth outcomes. 
Within the neuroendocrine system, corticotropin stimulates secretion of cortisol by the adrenal 
cortex in response to stressors. Elevated cortisol inhibits release of corticotropin by the anterior 
pituitary gland and inhibits release of corticotrophin releasing hormone (CRH) by the 
hypothalamus. Chronic emotional or physical stress can interrupt this negative feedback loop, 
resulting in an overproduction of cortisol46 - making cortisol a good metric for measuring stress 
levels. Maternal stress has been shown to be associated with increases in placental, decidual, and 
amniochorionic expression of CRH.40 In vivo studies have found significant correlations among 
maternal pituitary–adrenal stress hormones such as cortisol and placental CRH levels. 47-50 CRH 
acts directly on the uterus and cervix and interacts with both prostaglandins and oxytocin, the 
two major uterotonics that mediate the stimulation and maintenance of myometrial contractility 
at term and during labor.51 Thus a potential mechanism may be that stress leads to elevated 
cortisol levels, which cause unregulated CRH levels, and in turn poor birth outcomes. 
Few studies, however, have thoroughly examined the causal relation of cortisol with birth 
weight.  In addition, extant literature relies on observational case-control and cohort studies, 
which may be subject to residual confounding. Furthermore, these studies have often analyzed 
self-reported measures of stress, which may be susceptible to recall bias, or may lead to 
misclassification due to differential perceptions of stress, which could generate an association of 
maternal stress with birth weight.  
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To clarify the effect of cortisol exposure on LBW, we conducted a two-sample 
Mendelian randomization (MR) study, i.e., a study design using genetic variants as instruments, 
Given, that genetic variants are allocated randomly at conception, MR, a quasi-experimental 
study design, is less susceptible to confounding and so provides an alternative means of 
assessing the causal effect of cortisol on LBW. 
 
Methods 
I conducted a two-sample Mendelian randomization (MR) study to assess the effect of plasma 
cortisol exposure on LBW. Summary genetic associations from two different existing genome-
wide association studies (GWAS) were obtained. As is described by Greenland154 and others155, 
MR is dependent on the assumptions of instrumental variable (IV) analysis: a) relevance, i.e., the 
instrument predicts the exposure, b) exclusion restriction, i.e., the instrument affects the 
outcome only through affecting the exposure, c) independence, i.e., the instrument does not share 
common causes with the outcome.  
 
Plasma cortisol (exposure to indicate stress). Published genetic predictors of morning plasma 
cortisol were obtained from Crawford et al. (2019) 110 based on a genome wide association study 
(GWAS) of morning plasma cortisol conducted by the the CORtisol NETwork (CORNET) 
consortium (n=12,597) largely in people of European descent. The consortium performed a 
meta-analysis of genome-wide association studies of morning plasma cortisol from 11 western 
European population-based cohorts: CROATIA-Vis (n = 885), CROATIA-Korcula (n = 898), 
CROATIA-Split (n = 493), ORCADES (n = 886), Rotterdam Study (n = 2945), NFBC1966 (n = 
1195), Helsinki Birth Cohort Study 1934–44 (n = 451), ALSPAC (n = 1567), InChianti (n = 
1207), PREVEND (n = 1151), and PIVUS (n = 919). Replication was tested in 2,795 subjects 
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from three independent cohorts: Raine Study (n = 797), ET2DS (n = 1,069), and MrOS-Sweden 
(n = 929). Cortisol was measured by immunoassay in blood samples collected from study 
participants between 0700 and 1100 h. Inclusion criteria were adults aged 17 years or older from 
Caucasian populations. 
We used the SNPs in low linkage disequilibrium (r2 < 0.3) associated with morning 
plasma cortisol at p-value < 5 × 10−6, which explain approximately 0.5% of the variation in 
plasma cortisol. We assessed whether any of these SNPs were associated with hypothesized 
potential confounders based on confounders that have been controlled for in the existing 
observational literature (maternal smoking, body-mass index, age, education, socioeconomic 
status, and area deprivation) using a curated genotype to phenotype cross-reference, 
Phenoscanner (http://www.phenoscanner.medschl.cam.ac.uk) . To satisfy the exclusion-
restriction assumption, we also searched PhenoScanner for paths by which the SNPs predicting 
plasma cortisol might affect birth weight other than via plasma cortisol. 
 
Birth weight (outcome). Maternal genetic associations with offspring birth weight were 
obtained from the Early Growth Genetics Consortium (EGGC) GWAS of birth weight. We used 
genetic associations representing mother's genetic effect on offspring birth weight, after 
adjusting for offspring's genotype,72 as the genotype most closely corresponding to maternal 
exposures during pregnancy. The EGGC GWAS included 264,498 women of European descent, 
179,360 for whom offspring birth weight was available, and combined data from the EGG 
consortium and the UK Biobank data (released May 2017). The 12 studies from the EGG 
Consortium conducted genome-wide association analysis on offspring birth weight that was Z-
score transformed, and adjusted for sex, gestational duration and ancestry informative principal 
components where necessary. The UK Biobank is a study of 502,655 participants.108 Of this 
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population, 216,839 women reported the birth weight of their first child on at least one 
assessment center visit. Values were recorded to the nearest whole pound, and were converted to 
kilograms. Where women reported the birth weight of the first child at multiple time points these 
were averaged and women were excluded if the mean difference between any 2 offspring BW 
measurements was >1kg (N=31). Women who reported the BW of their first child <2.2kg 
or >4.6kg were excluded (N=6,333). Data from the EGG consortium were imputed to the 1000 
Genomes Project (Phase 1 v3) reference panel and data from the UK Biobank were imputed to 
the HRC reference panel. All birth weight measures were z-score transformed. Genetic 
associations with maternally determined birth weight were obtained using linear regression in the 
EGG consortium and a linear mixed model in the UK Biobank, with adjustment for gestational 
age where available and study specific covariates.72 A European ancestry fixed-effects meta-
analysis was used to combine the association summary statistics from the two sources using 
GWAMA Warrington et al. then used a structural equation modeling (SEM) approach to 
estimate maternal and fetal effects independent of the fetal and maternal genotype respectively. 
Briefly, to estimate the parameters for the SEM-adjusted fetal and maternal effects on BW, three 
observed variables were used; participant’s genotype, their own self-reported BW, and the BW 
of their first child. Additionally, the model comprises two latent (unobserved) variables, one for 
the genotype of the participant’s mother and one for the genotype of the participant’s offspring.  
Statistical analysis. The F-statistic for instrument strength was calculated using an 
approximation - the SNP-exposure association squared divided by the variance of the SNP-
exposure association squared. 127 SNPs were aligned on allele letter as none were palindromic. 
SNP-specific Wald estimates (SNP on outcome divided by SNP on exposure) were meta-
analyzed using inverse variance weighting (IVW), which assumes balanced pleiotropy. MR 
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Egger, which is able to assess whether genetic variants have pleiotropic effects on the outcome 
that differ on average from zero,156 was used as a sensitivity analysis. However, its validity with 
only 3, correlated genetic variants, is questionable. Commix was also used.130 Correlations 
between SNPs obtained from ld_matrix (https://ldlink.nci.nih.gov/) were taken into account. 
Power analysis.  The sample size needed for an MR study can be approximated by the sample 
size needed for exposure on outcome divided by the r2 for instrument on exposure,131 which was 
estimated using an online calculator https://sb452.shinyapps.io/power.157 
Ethics. All data used in this study is publicly available with no direct involvement of participants 
in the study. A form was submitted to the CUNY SPH IRB and this research was deemed exempt 
from formal review. 
Data availability. The datasets analyzed in this study are publicly available summary statistics. 
Statistical packages. All analyses conducted using R version 4.0.2 (R Foundation for Statistical 




Genetic associations with cortisol. None of the single nucleotide polymorphisms (SNPs) for 
cortisol (rs12589136, rs2749527, rs11621961) were associated with hypothesized potential 
confounders based on confounders that have been controlled for in the existing observational 
literature, including maternal smoking, body-mass index, age, education, socioeconomic status, 
or area deprivation. Given the SNPs explained ~0.5% of the variance of plasma cortisol, with a 
sample size of 179,360, the study had 80% power to detect about a 0.1 standard deviation (SD) 
(approximately 49 grams158) difference in birth weight for every unit increase of log transformed 
effect size of plasma cortisol using an alpha of 0.05.  The average F-statistic was 39.6. 
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Association of plasma cortisol with birth weight. Table 1 shows genetically instrumented 
plasma cortisol was inversely related to birth weight using inverse variance weighting (IVW) 
accounting for correlations between the SNPs used as instruments (shown in Supplementary 
Tables 1 and 2). Birth weight decreased about 19 grams (.057 SDs) for every unit increase of log 
transformed effect size of plasma cortisol (beta = -.057 (95% confidence interval (CI) -.103, 
-.021). Additionally, genetically instrumented plasma cortisol was inversely related to birth 
weight using commix. Birth weight decreased about 21 grams (.06 SDs) for every unit increase 
of log transformed effect size of plasma cortisol (beta = -.06 (95% confidence interval (CI) -.13, 
-.01). The MR Egger estimate was smaller but in the same direction. 
 
Discussion 
This study suggests that higher mother’s plasma cortisol reduces infant birth weight. 
These findings are consistent with previous observational studies that concluded that increased 
maternal cortisol levels are associated with restricted intrauterine growth and lead to lower fetal 
weight.43,44,159,160 These findings, however, contradict another observational study that found 
maternal cortisol levels were negatively related to offspring birth weight but that this association 
was not significant after adjustment for gestational age at birth, infant gender, ethnicity, maternal 
age, parity, body mass index (BMI), and smoking.45Our study builds on previous research by 
using a quasi-experimental approach to answer a question that had previously only been explored 
through observational methods.  
Provided the assumptions are upheld, the MR study design provides unconfounded 
estimates and here takes advantage of existing resources. An additional strength of the study 
design is that the exposure and the outcomes came from different samples, reducing the risk of 
confounding by a shared data structure. Using samples largely from people of European descent, 
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with genomic control, reduces the risk of bias from population stratification. Using very large 
samples means the study had power to detect small differences. 
 However, an MR study is also limited by its three underlying assumptions, which cannot 
all be empirically verified. First, the study design assumes a strong association of each 
instrument with plasma cortisol. The average F-statistic was 39.6, where a value greater than 10 
is taken as adequate strength.161 Furthermore, these SNPs have some physiological validity as 
instruments in being related to total cortisol-binding activity plasma and have been used in 
previous studies.110 The SERPINA6 gene on which they are found codes for corticosteroid-
binding globulin (CBG), which binds to cortisol in the blood.162 As such, we did not use a 
positive control outcome to test that these genetic variants for cortisol had the expected effects of 
cortisol. Second, no confounders of genetic predictors on outcome should exist. Using 
Phenoscanner, we did not identify any confounders associated with the genetic instruments. 
Lastly, the genetic instruments should only affect birth weight via plasma cortisol. To assess for 
potential horizontal pleiotropy, where a genetic variant influences multiple outcomes through 
independent pathways, Phenoscanner was used and found no known direct association of any of 
the SNPs for cortisol with birth weight, or factors that might affect birth weight. We conducted 
sensitivity analyses using analytic methods designed to address potential pleiotropy (e.g., MR 
Egger). We do not know of other stress-related mechanisms associated with cortisol that might 
affect birth weight so we did not use multivariable MR to disentangle the effect of cortisol on 
birth weight from that of other correlated exposures. We also used genetic associations with birth 
weight controlled for offspring genetics, eliminating the possibility that the association of 
maternal genetics with birth weight was acting through offspring genetics. Finally, although less 
commonly stated, MR assumes that the association of SNPs with exposure and outcome are free 
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from selection bias, including survival bias.163 The GWAS of plasma cortisol and birth weight 
were conducted in relatively young people; genetic predictors of cortisol were obtained from a 
study of men and women of mean age 54.6 years and genetic predictors of birth weight were 
assessed among women of reproductive age. In addition, cortisol is not thought to affect 
mortality and birth weight is not thought to share common causes with conditions that cause 
death at earlier ages. As such, selection bias is less likely. We still must consider, however, the 
possibility that selection bias occurred because mothers who experienced miscarriage due to 
stress acting via cortisol might also have been going to have a baby with low birth weight, 
however these potential births would have been excluded from the analysis. In these 
circumstances the observed relation of maternal cortisol with birth weight would be attenuated 
by focusing only on those who survived to birth.  
 Several other potential limitations relate to the study design. For example, MR studies 
often lack power related to the modest effects of genotype for most complex phenotypes. It is 
recommended that to avoid this issue one use genotypes with reliably established association 
with exposures, meaning that the associations have been replicated in several independent 
studies, and ideally can be confirmed within the MR study.101 The study included three SNPs 
(rs12589136, rs2749527, rs11621961) associated with morning plasma cortisol located in the 
SERPINA6 gene. The SERPINA6 gene codes for corticosteroid-binding globulin (CBG), which 
binds to cortisol in the blood, and thus is of known phenotype.  The data that the study utilized 
come from self-reported measures of infant birth weight, which might be unreliable.  We tried to 
account for this by removing extreme values or values that were different between two reports. 
Findings from MR studies are also difficult to interpret and the clinical significance of estimates 
is not easy to discern. 
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 Population stratification can lead to results biased by confounding of the associations of 
genotype on disease in the study population.137 Here, bias from population stratification is 
unlikely because the underlying studies included samples largely from people of European 
descent with appropriate genomic control. Canalization, or developmental compensation, is also 
possible.138 However, the extent to which it occurs, if any is unknown. Cortisol may have 
different effects in different populations although cortisol is not known to operate by population 
specific mechanisms. As such, though we are using MR among European populations to explore 
causality, the implications of this study may be extrapolated to women of color who tend to 
experience higher levels of stress during pregnancy. 4,33-35,142 Using publicly available data 
precludes subgroup analysis by sex and age. Genetic predictors of cortisol were obtained from a 
study of men and women of mean age 54.6 years because sex-specific genetic predictors are not 
available. However, the effects of cortisol are not known to differ by sex. We also cannot 
exclude the possibility that genetic predictors of cortisol might have different effects in pre- and 
post-menopausal women. 
 These findings are biologically plausible as there is evidence from human and animal 
models that cortisol crosses the placenta from the mother to the fetus.164 It has also been found 
that despite the effects of placental 11β hydroxysteroid dehydrogenase type 2, which deactivates 
cortisol, trans-placental transfer of cortisol is sufficient to affect fetal growth and physiology.165 
Analogous studies in sheep concluded that hydrocortisone infusion during pregnancy in sheep 
affects fetal growth.166  Additionally, exposure to antenatal dexamethasone treatment results in 
decreased birth weight corrected for gestational age.167 
 The results of this study provide a better understanding of the relation of maternal stress 
with birth outcomes, knowledge that is currently lacking due to the methodological limitations of 
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the existing studies that have been conducted on this subject. This information will be valuable in 
the prevention of birth outcomes for all women who may experience general and pregnancy-
related stress. These findings may be of particular importance for Black women who are exposed 
to more general and pregnancy-related stress than non-Hispanic White women, and may 
additionally face stress due to experience of racial prejudice and discrimination. 4,33-35,142 Causal 
knowledge of the effects of stress on fetal growth and development might pave the way for 
clinical guidelines pertaining to stress management during pregnancy. Some preliminary 
research suggests that chemical interventions may be successful in reducing cortisol levels 168-170 
and, as mentioned above, multiple RCTs how shown that behavioral interventions during 
pregnancy can reduce stress, though these studies did not include as assessment of effects on 
birth outcomes.145-151 Additional research and funding should be dedicated to the development 
and evaluation of stress reduction strategies during pregnancy.  
 
Conclusion  
I found cortisol to be a cause of lower birth weight. More investigation is required into the role 
of cortisol in causing LBW, a leading cause of morbidity and mortality among infants. For 
example, additional studies that explore the mechanism through which cortisol affects 
birthweight as well as other biological pathways through which stress might act on the 
developing fetus would be valuable to the field. A quasi-experimental study among women of 
color would also shed light on whether there are any racial differences in the effects of cortisol 
on birth weight. In the meantime, based on existing intervention research and the findings of our 
study, clinicians should consider prescribing stress reduction strategies and psychotherapy to 
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Inverse variance weighted -0.057 -0.105 to -0.008 0.021  0.21 (.89) 
MR-Egger -0.023 -0.965 to 0.919 0.962 -0.023 0.18 (.67) 
Conmix -0.06 -0.13 to -0.01 0.0417  N/A 
 
 
Supplementary Table 2.1. Associations of individual SNPs with cortisol and birth 
weightError! Bookmark not defined.,Error! Bookmark not defined.   
 
 Cortisol birth weight 
rsid effect 
allele 
beta se p-value effect 
allele 
Beta se p-value 
rs12589136 T 0.103 0.014 3.32E-12 T -0.007 0.005 0.157 
rs2749527 T -0.081 0.012 5.21E-11 T 0.0034 0.004 0.351 
rs11621961 T -0.077 0.014 3.97E-08 T 0.006 0.004 0.189 
 
 
Supplementary Table 2.2. Correlations among individual SNPS of interest from ldlink 
 
 rs12589136 rs2749527 rs11621961 
rs12589136 1.00 -0.233 0.437 
rs2749527 -0.233 1.00 0.491 


















Can racial disparities in birth outcomes be partially attributed to 
stress: a Mendelian randomization study of maternal blood 




In the United States (US), low birth weight (LBW) is a leading cause of infant death overall, and 
the leading cause of death for Black infants. Understanding and preventing adverse birth 
outcomes is a major public health priority in the US. Observationally, some evidence supports 
the hypothesis that the maternal vascular stress pathway may be associated with LBW. We used 
two-sample instrumental variable analysis using genetic instruments (Mendelian randomization) 
from genome wide association studies strongly (p-value < 5 × 10−8) and independently associated 
with diastolic blood pressure (BP), systolic blood pressure (BP), hypertension, applied to a large, 
extensively genotyped study of birth weight conducted by the Early Growth Genetics 
Consortium (EGGC), which gives mother's genetic effect on offspring birth weight, after 
adjusting for offspring's genotype (n =179,360). SNP-specific Wald estimates were combined to 
obtain inverse variance weighted (IVW), weighted median, MR-Egger and contamination 
mixture model (commix) estimates. Systolic BP was associated with birth weight using the 
weighted median and conmix. More investigation is required into the role of systolic BP in 






In the United States (US), low birth weight (LBW), defined as weighing 2,499 grams or 
less at birth, is a leading cause of infant death, particularly affecting Black infants.2 LBW is 
inversely associated with cognition,10 language development,11 and academic achievement,12,14 
and with greater need for special education.13 Furthermore, poor birth outcomes may be 
associated with health risks in adulthood15 including of cardiovascular disease,16 hypertension,17 
and non-insulin dependent diabetes mellitus.141 However, LBW could also be the result of socio-
economic characteristics, and associated disadvantages, which also lead to these health 
outcomes. 
Understanding and preventing adverse birth outcomes is a major public health priority in 
the US. Numerous case-control and cohort studies have demonstrated an association of exposure 
to general and pregnancy related stress with LBW.5-7,31,32 Furthermore, studies have consistently 
shown that Black women experience greater levels of general stress and pregnancy-related 
stress.4,33 Additionally, Black women are more likely to experience stress due to racism and 
discrimination, which is associated with worse birth outcomes.34,35,142 Increased exposure to 
stress during pregnancy may begin to partially explain racial disparities in birth outcomes in the 
US.143,144 
Acute psychological stressors evoke cardiovascular responses as the result of 
neurological changes typically characterized by increases in sympathetic and parasympathetic 
activity, which lead to changes in outflow to the heart and vascular system.Error! Bookmark 
not defined. Typically this leads to an elevated blood pressure (BP). This was initially viewed as 
a function of the body’s reaction to deal with perceived threats.171 For most individuals, these 
vascular reactions are acute so BP drops once a stressor has been removed, or once an individual 
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has adjusted to the stressor.171 However, individuals who experience exaggerated or chronic 
stress may also experience prolonged stressor-evoked cardiovascular reactions.171 These 
reactions can lead to sizable and sustained rises in BP.  
 Women who experience heightened vascular reactivity may be at increased risk of low 
birth weight. Many observational studies have suggested that higher maternal BP is associated 
with lower offspring birth weight.52-70 However, these studies may be subject to residual 
confounding due to common causes of exposure and outcome such as socioeconomic position 
that were not considered or that were not adjusted for, given the difficulty of comprehensively 
capturing such information. Unfortunately, an experimental randomized control trial (RCT) 
cannot ethically be conducted on this topic. Instead, several quasi-experimental studies using 
Mendelian randomization which takes advantage of naturally existing random variation in 
maternal genetics and is thus less open to confounding, have also demonstrated a relationship of 
higher maternal BP with lower offspring birth weight.71-73 These findings, however, are limited 
by small sample size, use of data pertaining to both men and women, lack of adjustment for the 
effects of fetal genetics on birth weight, or focus limited to the independent effects of systolic 
and diastolic blood pressure, when these are related exposures. 
To clarify the effect of stress induced vascular reactivity on LBW, we conducted a two-
sample Mendelian randomization (MR) study, i.e., an unconfounded study design using genetic 
variants as instruments.101 Vascular reactivity was measured here as blood pressure (BP), a 
known outcome of stress that has additionally been studied as a potential cause of low birth 
weight.  This study fills a current gap in the quasi-experimental literature by using sex-specific 
genetically instrumented BP and adjusting for offspring genetics. We also implemented a 
multivariable MR analysis in order to assess independent effects of several vascular attributes 
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(e.g., diastolic BP, systolic BP). We also used ischemic heart disease (IHD) as a positive control 
outcome because blood pressure is known to cause IHD. 
 
Methods 
We conducted a two-sample univariable and multivariable MR study to assess the effect of 
systolic BP and diastolic BP on birth weight. Additionally, we included history of hypertension 
as an exposure, which accounts not only for the participants BP measure at time of assessment, 
but also whether the participants reported use of antihypertensive medication or doctor-
diagnosed hypertension. As is described by Greenland154 and others155, MR is dependent on the 
assumptions of instrumental variable (IV) analysis: a) relevance, i.e., the instrument predicts the 
exposure, b) exclusion restriction, i.e., the instrument affects the outcome only through affecting 
the exposure, i.e., there is no selection bias from selecting on common effects of the instrument 




Genetic associations with systolic BP, diastolic BP and hypertension were extracted from the UK 
Biobank summary statistics for women only. The UK Biobank is one of the largest biobanks 
globally. It recruited over 500,000 participants (intended to be aged 40–69 years) in England, 
Scotland and Wales from 2006 to 2010. Participants completed a questionnaire and a 
comprehensive assessment at baseline, genotyping, and longitudinal follow-up via record linkage 
to medical and mortality records is ongoing, as described in detail elsewhere.111-113 Genotyping 
was performed using two very similar arrays, including Affymetrix UK BiLEVE, Axiom array, 
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and Affymetrix UK Biobank Axiom array. Further information on the genotyping process is 
available on the UK Biobank website (http://www.ukbiobank.ac.uk/scientists-3/genetic-data).114 
Summary sex-specific genetic associations adjusted for age, age2, and the first 20 principal 
components are publicly available (http://www.nealelab.is/uk-biobank) and were used to obtain 
genetic instruments for the exposures. 
 
Diastolic BP and SBP. Blood pressure was assessed using digital blood pressure monitors 
(HEM-7015IT; Omron Healthcare Inc) during the initial assessment visit (2006-2010). The 
average of two blood pressure measurements taken at least 1-minute apart was used. Diastolic 
BP data was available for 182,647 women and systolic BP was available for 157,514 women. 
 
Hypertension. Participants were classified as having hypertension if systolic BP ≥140 mmHg, 
diastolic BP ≥90 mmHg, self-reported use of antihypertensive medication, or self-reported 
doctor-diagnosed hypertension. Hypertension data were available for 194,153 women. 
 
Outcome 
Genetic associations with maternal genetic effects on birth weight were extracted from the Early 
Growth Genetics Consortium (EGGC) genome-wide association study (GWAS) of birth weight. 
Genetic associations representing mother's genetic effect on offspring birth weight, after 
adjusting for offspring's genotype,72 are the genotype most closely corresponding to maternal 
exposures during pregnancy. The EGGC GWAS included 264,498 women of European descent, 
179,360 for whom offspring birth weight, measured as a continuous variable, was also available, 
from the EGGC and the UK Biobank data (released May 2017). The 12 studies from the EGGC 
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conducted genome-wide association analysis of z-score transformed offspring birth weight 
adjusted for sex, gestational duration and ancestry informative principal components where 
necessary. The UK Biobank included 502,655 participants.108 Of the 273,467 women, 216,839 
reported the birth weight of their first child at one assessment center visit, given not all women 
have children. Values were recorded to the nearest whole pound, and converted to kilograms. 
Where women reported the birth weight of the first child at multiple time points these were 
averaged and women were excluded if the mean difference between any 2 offspring BW 
measurements was >1kg (N=31). Women who reported BW of their first child <2.2kg or >4.6kg 
were also excluded (N=6,333). Genetic estimates in EGGC were imputed to the 1000 Genomes 
Project (Phase 1 v3) reference panel and in the UK Biobank were imputed to the HRC reference 
panel.72 Genetic associations with maternally determined birth weight were obtained using linear 
regression in the EGG consortium and a linear mixed model in the UK Biobank, with adjustment 
for gestational age, where available, and study specific covariates.72 A structural equation 
modeling (SEM) approach was used to estimate maternal and fetal effects independent of the 
fetal and maternal genotype respectively including the observed participant’s genotype, their 
own self-reported BW, and the BW of their first child, and two latent (unobserved) variables, for 
the genotype of the participant’s mother and for the genotype of the participant’s offspring. We 
have assumed a linear relationship between BW and measures of exposure. 
 
Statistical analysis.  
In order to ensure the relevance assumption was met, we used all single nucleotide 
polymorphisms (SNPs) which strongly (p-value < 5 × 10−8) and independently (r2<0.05) 
predicted each exposure.  We checked the strength of genetic instruments from the F-statistic 
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using an approximation - the SNP-exposure association squared divided by the variance of the 
SNP-exposure association squared.172 An F-statistic < 10 indicates a weak instrument.161 We 
ensured palindromic SNPs were aligned on allele frequency, or replaced by highly correlated 
proxy. To assess the independence assumption was met, we assessed whether any of these SNPs 
were associated with potential confounders based on confounders that have been controlled for 
in the existing observational literature, including body mass index (BMI), weight, height, overall 
health status, maternal birth weight and smoking, using a curated genotype to phenotype cross-
reference, Phenoscanner http://www.phenoscanner.medschl.cam.ac.uk. To address the exclusion-
restriction assumption, we also searched PhenoScanner for paths by which the SNPs might affect 
birth weight other than by causing BP, or hypertension and removed any SNPs that met this 
criterion.  
To obtain an MR inverse variance weighted (IVW) estimate, SNP-specific Wald 
estimates (SNP on outcome divided by SNP on exposure) were meta-analyzed with 
multiplicative random effects, which assumes balanced pleiotropy.173 Additionally, we used a 
weighted median estimate, which assumes that instruments representing over 50% of the weight 
are valid instrumental variables, MR Egger, which assess pleiotropic genetic effects on the 
outcome that differ on average from zero, and contamination mixture model (commix), which 
has a contrasting plurality valid assumption and may be the best method, judged by mean 
squared error.126,130,172 Given diastolic and systolic BP are highly correlated, to identify their 
independent effects, we conducted a multivariable MR analysis using IVW, weighted median 
and MR-Egger estimates. Multivariable MR is designed to identify the independent effects of 
two or more exposures on the same outcome.174  In order to select SNPs for the multivariable 
MR, first, all SNPs for diastolic BP and systolic BP that were significantly associated with the 
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respective exposures at p-value < 5 × 10−8 were retained. Any correlated SNPs were removed 
using the lower of the two p-values. Multivariable MR estimates were obtained using, IVW, 
weighted median, and MR-Egger. 
We calculated the corresponding multivariable conditional F and Q statistics to test for 
instrument strength and pleiotropy.174 Given, we used summary data with the same sample for 
the exposures, the conditional F-statistic likely represents a lower bound and the Q-statistic an 
upper bound.174 
Power analysis.  The sample size needed for an MR study can be approximated by the sample 
size needed for exposure on outcome divided by the r2 for instrument on exposure,131 which was 
estimated using an online calculator https://sb452.shinyapps.io/power.157 
 
Ethics. All data used in this study is publicly available with no direct involvement of participants 
in the study. CUNY SPH IRB deemed this research exempt from formal review. 
 
Data availability. The datasets analyzed in this study are publicly available summary statistics 
available at https://egg-consortium.org/ and http://www.nealelab.is/uk-biobank. 
 
Statistical packages. All analyses conducted using R version 4.0.2 (R Foundation for Statistical 
Computing, Vienna, Austria), and the “MendelianRandomization”, “TwoSampleMR”, and 
“MVMR” packages.  
 
Results 
Genetic associations with exposures.  
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One hundred fifty-seven, 47, and 83 SNPs strongly predicted (p-value < 5 × 10−8) systolic 
BP, diastolic BP, and hypertension, respectively (see Table 1). All of these SNPs had F-
statistics > 20. Of these SNPs, 57 associated with systolic BP, 18 associated with diastolic BP, 27 
associated with hypertension were found to be associated with potential confounders based on 
confounders that have been controlled for in the existing observational literature, including BMI, 
weight, height, overall health status, maternal birth weight, and smoking, or were associated with 
other factors that might affect birth weight and lead to pleiotropic effects using Phenoscanner 
(see Table 2). Estimates were calculated both including and excluding the aforementioned SNPs. 
The SNPs selected for blood pressure were all significantly associated with the positive control 
IHD (systolic IVW Beta = -0.014, p-value = .007, diastolic IVW Beta = -0.014, p-value < .001). 
Given the SNPs explained ~0.018% of the variance of blood pressure, with a sample size 
of 157,514 for diastolic blood pressure and 182,647 for systolic blood pressure at 80% power 
and 5% alpha, the study could detect an effect size of about 0.05 (OR = 1.05). Given the SNPs 
explained ~0.003% of the variance of hypertension, with a sample size of 179,360, at 80% power 
and 5% alpha the study could detect an effect size of about 0.12 (OR = 1.13).  
 
Univariable associations with birth weight. Table 3.1 and 3.2 show systolic BP was inversely 
associated with birth weight using the weighted median and conmix, but not using IVW or MR-
Egger. Hypertension was not clearly associated with birth weight in table 3.2 and diastolic blood 
pressure was not associated with birth weight in either analysis.  
 
Multivariable associations with birth weight. No independent associations of systolic or 
diastolic BP with birth weight were evident. The conditional F statistics for the MVMR model 
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are 12.7 and 21.5 and the Cochran’s Q statistic was 423.6 (p<.001). These associations were the 
same including and excluding confounding or potentially pleiotropic SNPs and when orienting 
on systolic and diastolic BP.  
 
Discussion 
This study suggests that mother’s systolic blood pressure may have an effect on infant 
birth weight. This finding is in line with the hypothesis that stress might act through blood 
pressure to cause low birth weight and supports the findings of existing MR studies on this topic, 
which found maternal systolic BP reduced birth weight.71-73 Unlike the existing MR studies on 
this topic, this study 1) used sex-specific genetically instrumented BP and adjusted for offspring 
genetics 2) implemented a multivariable MR analysis in order to assess independent effects of 
several vascular attributes (e.g., diastolic BP, systolic BP) and 3) used a positive control outcome 
to validate our instrument selection.71-73 Unlike Warrington et al. 72, who found a causal 
relationship between systolic BP and LBW, we also did not adjust for BMI in the selection of our 
instruments  because adjusting for heritable covariates, such as BMI, may bias the genetic 
estimates for blood pressure if common causes of BMI and blood pressure exist.117 This type of 
adjustment is known to lead to false positives. The fact that we obtained a similar result despite 
not controlling for this covariate suggests that we cannot exclude an effect of systolic BP on birth 
weight.	
If blood pressure has a causal effect on fetal growth and development, this knowledge 
might affect clinical guidelines pertaining to stress management during pregnancy, both from the 
perspective of lived experiences and medical management. Many effective interventions exist to 
regulate BP.175 Some evidence suggests that decreasing maternal blood pressure during 
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pregnancy prevents poor birth outcomes.176,177 However, other findings suggest that benefit is 
unlikely to result from treating hypertension in pregnancy.178  Multiple RCTs how shown that 
behavioral interventions during pregnancy can also reduce stress.24,25,26,27,27,29,30 Yet, the US is 
unique among developed countries in having minimal maternity leave and no universal provision 
of care in pregnancy. As a result, many expectant mothers in the US receive no prenatal care, or 
initiate care late in pregnancy, despite evidence that birth outcomes are better in countries with 
increased access to and use of prenatal care.179 Additional research and funding should be 
dedicated to the development and evaluation of blood pressure management and stress reduction 
strategies during pregnancy and to the creation of universal prenatal care programs within the 
US.	
This study’s primary strength is that is used an MR design, which has the advantage of 
providing unconfounded estimates, re-using existing resources and providing estimates even 
when no study including comprehensive information on exposure and outcome exists.  An MR 
study, however, is limited by three underlying assumptions. First, the relevance assumption, 
which assumes each instrument strongly predicts each exposure. However, our average F-
statistics were over 20. Second, the independence assumption, no confounders of genetic 
predictors on outcome should exist, but using Phenoscanner, we identified and eliminated any 
SNPs associated with potential confounders. Lastly, the exclusion-restriction assumption - 
genetic instruments should only affect birth weight via affecting the exposure. To assess for 
potential horizontal pleiotropy, where a genetic variant influences the outcomes through an 
independent pathway, Phenoscanner was used to identify direct associations of any of the SNPs 
for DBP, SBP, or hypertension with birth weight, or factors that might affect birth weight. 
Analysis was conducted with and without these SNPs. Finally, although less commonly stated, 
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MR assumes that the association of SNPs with exposure and outcome are free from selection 
bias, particularly bias arising from the recruiting participants who have survived the exposure 
and competing risk of the outcome.163 The GWAS of exposures and birth weight were conducted 
in relatively young people, however, among women who know they are pregnant, the 
miscarriage rate is thought to be between 10% to 20%.180 Conceptions of smaller infants 
miscarried due to maternal BP would bias the estimates towards the null.  
  Bias from population stratification, differences in allele frequencies between 
subpopulations as a result of non-random mating between individuals, is unlikely because the 
underlying studies included samples largely from people of European descent with genomic 
control. Canalization, or the ability of a population to produce the same phenotype regardless of 
variability of its genotype, is also possible.181 However, the extent to which it occurs, if any is 
unknown. Causes are generally expected to act consistently, but may not be relevant to all 
populations.135 As such, the findings are not only generalizable to white, European populations, 
but also transportable to non-European populations of color. In other words, we have no reason 
to believe that blood pressure would affect LBW differently in different geographical or 
racial/ethnic populations. 
 There are some additional limitations to this study. First, these instruments used in this 
study have not been replicated, so we used ischemic heart disease, which is known to be 
associated with blood pressure, as a control outcome and found that ischemic heart disease was 
significantly associated with blood pressure.  Second, our estimates are not adjusted for whether 
study participants are currently taking any BP medication, which some participants likely were 
based on how the hypertension variable was operationalized, which might lead to imprecision, 
likely, biasing towards the null. Third, we have assumed that genetic variants identified in these 
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large GWAS of our exposures variables in non-pregnant women are similarly associated in 
pregnant women. Fourth, we have assumed that the critical period of exposure to maternal 
indirect genetic effects is pregnancy, and that the estimates do not reflect pre-pregnancy effects 
on primordial oocytes or post-natal effects.182 Fifth, despite large sample sizes, as any other 
instrumental variable approach, this MR study suffers from limited statistical power. In particular 
the lack of association with hypertension could be a power issue. Dichotomous outcomes have 
the advantage of representing a specific condition, but do not take advantage of the full 
variability in the underlying condition, such as duration and severity. Sixth, a practical difficulty 
of determining which variants to include in a MR analysis is that of multiple testing. Though we 
could have used a Bonferroni-corrected p-value threshold to take into account the number of 
comparisons made, we opted not to because an approach that adjusts for multiple comparisons 
may lead to a lack of power to detect any specific association. Additionally, as several genetic 
variants may be correlated, a simple Bonferroni correction may be an over-
correction.122 Seventh, we have presented three types of MR estimates, each of which represents 
a different approach for combining data, but we have no way of knowing the “right” answer, and 
there is no hierarchy in terms of robustness or reliability or estimates. However, current advice 
suggests that conmix might be most informative. Regardless of method used, the validity of our 
findings is still dependent on the integrity of the underlying GWAS. Finally, this study is limited 
in scope in that it only looks at one possible pathway between stress and LBW, and also does not 




The effect of maternal systolic BP cannot be excluded. More investigation is required into the 
role of the maternal vascular stress pathway in preventing LBW, a leading cause of morbidity 
and mortality among infants, particularly infants of color. In the meantime, based on existing 
intervention research, clinicians should consider implementing comprehensive prenatal care 
programs including the prescription of stress reduction strategies to help mitigate the effects of 






























Table 3.1. Mendelian randomization estimates for associations of maternal vascular 
reactivity with birth weight 
 
Exposure 












0.010  -0.047, 0.068 0.724  506.6 (<.001) 
Weighted median 0.040 -0.013, 0.093 0.141   
MR-Egger -0.040  -0.259, 0.179  0.721 0.640  





-0.069 -0.174, 0.035 .192  169.9 (<.001) 
Weighted median -0.133 -0.226, -0.041 0.005   
MR-Egger 0.219 -0.151, 0.589 0.246 0.112  





0.041 -0.162, 0.244 0.693  351.3 (<.001) 
Weighted median 0.149  -0.021, 0.319 0.086   
MR-Egger 0.183  -0.551, 0.916 0.626 0.693  









Table 3.2. Mendelian randomization estimates of blood pressure and hypertension with 


































MR-Egger 0.007    -0.229, 0.243   0.95
6 
0.702  







0.084      
-0.185, 0.017 0.10
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MR-Egger 0.132 -0.539, 0.804 0.69
9 
0.716  





Table 3.3. Multivariable mendelian randomization estimates for associations of systolic and 










IVW Diastolic BP 0.005     -0.070, 0.081 0.891 
Systolic BP -0.007 -0.112, 0.099 0.902 
Weighted 
Median 
Diastolic BP -0.020 -0.090, 0.049 0.567 
Systolic BP -0.038 -0.141, 0.064 0.460 
MR Egger Diastolic BP 0.001 -0.204, 0.109 0.550 
 Systolic BP -0.048 -0.076, 0.078 0.986 



























Can racial disparities in birth outcomes be partially attributed to 
stress: a Mendelian randomization study of immune response as 
a cause of low birth weight  
 
Abstract 
In the United States (US), low birth weight (LBW) is a leading cause of infant death overall, and 
the leading cause of death for Black infants. Understanding and preventing adverse birth 
outcomes is a major public health priority in the US. Observationally, some evidence supports 
the hypothesis that maternal immune function may be associated with LBW. To clarify the effect 
of maternal immune function on LBW, we used two-sample instrumental variable analysis using 
genetic instruments (Mendelian randomization) from genome wide association studies strongly 
(p-value < 5 × 10−8) and independently associated with white blood cell count (WBC), eosinophil 
count, neutrophil count, IL6 and IL1ra in women, applied to a large, extensively genotyped study 
of birth weight conducted by the Early Growth Genetics Consortium (EGGC), which gives 
mother's genetic effect on offspring birth weight, after adjusting for offspring's genotype (n 
=179,360). SNP-specific Wald estimates were combined to obtain inverse variance weighted 
(IVW), weighted median, MR-Egger estimates and contaminated mixed method (commix) 
estimates. Eosinophil count was inversely associated with birth weight using IVW and MR 
Egger methods and positively associated with WBC count using weighted median and commix 
after removing SNPS associated with potential confounders. More investigation is required into 
the role of maternal immunity in LBW, a leading cause of morbidity and mortality among 





In the United States, LBW, defined as weighing 2,499 grams or less at birth, is a leading 
cause of infant death, particularly affecting Black infants.2 LBW is inversely associated with 
cognition,10 language development,11 and academic achievement,12,14 and with greater need for 
special education.13 Furthermore, poor birth outcomes may be associated with health risks in 
adulthood15 including of cardiovascular disease,16 hypertension,17 and non-insulin dependent 
diabetes mellitus.141 However, LBW could also be the result of socio-economic characteristics, 
and associated disadvantages, which also lead to these health outcomes.183,184 
Understanding and preventing adverse birth outcomes is a major public health priority in 
the US. Numerous case-control and cohort studies have demonstrated an association of exposure 
to general and pregnancy related stress with LBW.5-7,31,32 Furthermore, studies have consistently 
shown that Black women experience greater levels of general stress and pregnancy-related 
stress.4,33 Additionally, Black women are more likely to experience stress due to racism and 
discrimination, which is associated with worse birth outcomes.34,35,142 Increased exposure to 
stress during pregnancy may begin to partially explain racial disparities in birth outcomes in the 
US.143,144 
Stress and distress are increasingly reported to be associated with immunosuppression. 
Just as the body may adjust blood pressure in a “fight or flight” response to stress, the body may 
also produce an adaptive immune response because fighting and fleeing carries the risk of injury 
and subsequent entry of infectious agents into the bloodstream or skin.185,186Error! Bookmark 
not defined. However, research has also shown that when stressors become chronic, components 
of the immune system begin to be affected in a potentially detrimental way,186 which may impair 
cellular immunity.187 
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Chronic stress and stress hormones appear to be associated with immunosuppression and 
changes in the normal pattern of cellular and humoral responses to antigens.188 This compounds 
the effects of pregnancy, which compromise a woman’s immunity. In a typical pregnancy 
alterations are produced in the maternal immune system to tolerate paternal major 
histocompatibility antigens and yet also to maintain adequate immune competence for defense 
against microorganisms.189,190 Changes that the mother experiences include a decline over the 
course of gestation in the ability of lymphocytes to proliferate in response to stimuli189 and a shift 
in the normal pattern of cytokine production from a T-helper cell 1 profile to a Th2 cytokine 
profile in pregnancy.190 
Very little research has been conducted to understand the stress–infection– immune system 
relationship in human pregnancy. 
Preliminary research suggests that perhaps maternal stress and infection work in concert 
to predict poor birth outcomes. In a cross-sectional investigation of a sample of 72 pregnant 
women, Herrera et al. reported that high levels of maternal psychological stress and low levels of 
social support were associated with lower lymphocyte activity.74 Furthermore, greater stress 
during pregnancy is associated with urogenital infections,75 which increases women’s risk for 
LBW.76 Microbial colonization and inflammation in the maternal genital tract has emerged as a 
major risk factor for spontaneous preterm birth.77 Leukocytes participate in the maintenance of 
pregnancy and alteration in their function or abundance may lead to labor at term or preterm.78 
Neutrophil and eosinophil infiltration of the uteroplacental tissues and amniotic fluid have been 
associated with preterm labor.79-81 The most prevalent lower genital tract infection in women of 
reproductive age, bacterial vaginosis (BV), is associated with a higher risk of LBW and preterm 
labor.82-84  
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Assessment of immune status most frequently involves the measurement of various leukocytes 
numbers in the blood stream, including total number of WBCs and the proportion of each 
subclass.191 Neutrophil counts for example are one possible of immune function. These cells are 
part of our innate immunity and are typically the most prevalent type of WBC. They are part of 
the body’s first line of immune defense and are responsible for immune response against 
invading pathogens as well as acting as part of the response to injury-induced inflammation.192 
Neutrophilia,  an increase in circulating neutrophils, is a classical indicator of acute 
inflammation, while neutropenia, an abnormally low number of neutrophils, predisposes one to 
infections.193 Eosinophils are also an interesting marker of immune function, as they are 
primarily responsible for destroying foreign substances194 Eosinophilia, or elevated levels of 
eosinophils, similarly indicates infection or inflammation.195 Finally, cytokines, specifically IL6 
and IL-1ra may also play an important role in immune/inflammatory responses during 
pregnancy.196-198and these can be targeted with well-known drugs, i.e., tocilizumab and anakinra 
respectively. 
 To the authors’ knowledge, however, no study has directly examined the effect of 
maternal white blood cell (WBC) count, eosinophil count, neutrophil count, IL6 or IL1ra on 
child’s birth weight. To clarify this relationship, we conducted a two-sample Mendelian 
randomization (MR) study, i.e., an unconfounded study design using genetic variants as 
instruments.101 This study fills a current gap in the literature and  produces robust estimates by 
using a quasi-experimental MR design, sex-specific genetically instrumented white blood cell 
counts, adjusting for offspring genetics, and assessing independent effects of several measures of 
WBC count (e.g., all leukocytes, eosinophils, neutrophils) and key cytokines. We also used 
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asthma and rheumatoid arthritis (RA) as positive control outcomes because WBC count, IL6 and 




We conducted a two-sample univariable MR study to assess the effect of total WBC count, 
eosinophil count, neutrophil count, IL6 and IL-1ra on birth weight. As is described by 
Greenland154 and others155, MR is dependent on the assumptions of IV analysis: a) relevance, 
i.e., the instrument predicts the exposure, b) exclusion restriction, i.e., the instrument affects the 
outcome only through affecting the exposure, c) independence, i.e., the instrument does not share 
common causes with the outcome. 
 
Exposures. 
Genetic associations with WBC count, eosinophil count, and neutrophil count were extracted 
from the UK Biobank summary statistics for women only. The UK Biobank is one of the largest 
biobanks globally. It recruited over 500,000 participants (intended to be aged 40–69 years) in 
England, Scotland and Wales from 2006 to 2010. Participants completed a questionnaire and a 
comprehensive assessment at baseline, genotyping, and longitudinal follow-up via record linkage 
to medical and mortality records is ongoing, as described in detail elsewhere.111-113 Genotyping 
was performed using two very similar arrays, including Affymetrix UK BiLEVE, Axiom array, 
and Affymetrix UK Biobank Axiom array. Further information on the genotyping process is 
available on the UK Biobank website (http://www.ukbiobank.ac.uk/scientists-3/genetic-data).114 
Summary sex-specific genetic associations adjusted for age, age2, and the first 20 principal 
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components are publicly available (http://www.nealelab.is/uk-biobank) and were used to obtain 
genetic instruments for the exposures. 
WBC counts were measured on fresh samples as an absolute number per unit volume, 
and their component leukocytes (lymphocytes, monocytes, neutrophils, eosinophils, and 
basophils) as absolute measures and proportions of the overall white blood cells. Complete blood 
cell counts (cells/L) were measured using a Coulter LH 750 System (Beckman Coulter, Brea, 
CA) as per manufacturer’s procedures. Further details of these measurements can be found in the 
UK Biobank online showcase and protocol (http://www.ukbiobank.ac.uk). Leukocyte count data 
were available for 188,074 women.  
Genetic predictors of IL6 and IL1ra were extracted from a MR study conducted by 
Schooling et al.202. We included one SNP (rs7529229) for IL6, and two SNPs (rs6743376 and 
rs1542176) for IL1ra. Other measures of immune function such as neutrophil to lymphocyte ratio 
and platelet to lymphocyte ratio have shown to be associated with pregnancy outcomes,203-210 but 
were not included in this study because ratio measures are open bias in the context of MR as they 
include two phenotypes that may share genetic predictors.117 
 
Outcome 
Genetic associations with maternal genetic effects on birth weight were extracted from the Early 
Growth Genetics Consortium (EGGC) genome-wide association study (GWAS) of birth weight. 
Genetic associations representing mother's genetic effect on offspring birth weight, after 
adjusting for offspring's genotype,72 are the genotype most closely corresponding to maternal 
exposures during pregnancy. The EGGC GWAS included 264,498 women of European descent, 
179,360 for whom offspring birth weight, measured as a continuous variable, was also available, 
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from the EGGC and the UK Biobank data (released May 2017). The 12 studies from the EGGC 
conducted genome-wide association analysis of z-score transformed offspring birth weight 
adjusted for sex, gestational duration and ancestry informative principal components where 
necessary. The UK Biobank included 502,655 participants.108 Of the 273,467 women, 216,839 
reported the birth weight of their first child at one assessment center visit. Values were recorded 
to the nearest whole pound, and converted to kilograms. Where women reported the birth weight 
of the first child at multiple time points these were averaged and women were excluded if the 
mean difference between any 2 offspring BW measurements was >1kg (N=31). Women who 
reported BW of their first child <2.2kg or >4.6kg were also excluded (N=6,333). Genetic 
estimates in EGGC were imputed to the 1000 Genomes Project (Phase 1 v3) reference panel and 
in the UK Biobank were imputed to the HRC reference panel.72 Genetic associations with 
maternally determined birth weight were obtained using linear regression in the EGG consortium 
and a linear mixed model in the UK Biobank, with adjustment for gestational age, where 
available, and study specific covariates.72 A structural equation modeling (SEM) approach was 
used to estimate maternal and fetal effects independent of the fetal and maternal genotype 
respectively including the observed participant’s genotype, their own self-reported BW, and the 
BW of their first child, and two latent (unobserved) variables, for the genotype of the 
participant’s mother and for the genotype of the participant’s offspring. We have assumed a 
linear relationship between BW and measures of exposure. 
 
Statistical analysis.  
In order to ensure the relevance assumption was met, we used all single nucleotide 
polymorphisms (SNPs) which strongly (p-value < 5 × 10−8) and independently (r2<0.005 
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predicted each exposure.  We checked the strength of genetic instruments from the F-statistic 
using an approximation - the SNP-exposure association squared divided by the variance of the 
SNP-exposure association squared.172 An F-statistic < 10 indicates a weak instrument. We 
ensured palindromic SNPs were aligned on allele frequency, or replaced by highly correlated 
proxy. To ensure the independence assumption was met, we assessed whether any of these SNPs 
were associated with potential confounders using a curated genotype to phenotype cross-
reference, Phenoscanner http://www.phenoscanner.medschl.cam.ac.uk. To satisfy the exclusion-
restriction assumption, we also searched PhenoScanner for paths by which the SNPs might affect 
birth weight other than by causing WBC count, eosinophil count, or neutrophil count and 
removed any SNPs that met this criterion. SNP-specific MR Wald estimates (SNP on outcome 
divided by SNP on exposure) were meta-analyzed using inverse variance weighting (IVW), 
which assumes balanced pleiotropy.173 Additionally, we used a weighted median estimate, which 
assumes that instruments representing over 50% of the weight are valid instrumental variables, 
MR Egger, which assess pleiotropic genetic effects on the outcome that differ on average from 
zero, and contamination mixture model (commix), which has a contrasting plurality valid 
assumption and may be the best method, judged by mean squared error.126,130,172 Multivariable 
MR was not conducted because each immune markers is thought to represent a distinct 
phenotype, unlike systolic and diastolic blood pressure in the previous study. 
Power analysis.  The sample size needed for an MR study can be approximated by the sample 
size needed for exposure on outcome divided by the r2 for instrument on exposure,131 using an 
online calculator for MR studies available at https://sb452.shinyapps.io/power.157 
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Ethics. All data used in this study is publicly available with no direct involvement of participants 
in the study. CUNY SPH IRB deemed this research exempt from formal review. 
 
Data availability. The datasets analyzed in this study are publicly available summary statistics 
available at https://egg-consortium.org/ and http://www.nealelab.is/uk-biobank.  
 
Statistical packages. All analyses conducted using R version 4.0.2 (R Foundation for Statistical 




Genetic associations with exposures.  
One hundred seventy-four, 169, and 159 SNPs were strongly and independently 
associated (p-value < 5 × 10−8) with WBC count, eosinophil count, and neutrophil respectively 
(see Table 1). All of these SNPs had F-statistics > 20. Of these SNPs, 33 associated with WBC 
count, 25 associated with eosinophil count, and 32 associated with neutrophil count were found 
to be associated with potential confounders based on confounders that have been controlled for 
in the existing observational literature, including BMI, weight, height, overall health status, and 
alcohol consumption, or were associated with other factors that might affect birth weight and 
lead to pleiotropic effects using Phenoscanner (see Table 2). Estimates were calculated both 
including and excluding the aforementioned SNPs. The SNPs selected for WBC count were all 
significantly associated with the positive control asthma (IVW Beta = 0.020, p-value = 0.001) 
and RA (IVW Beta = -0.005, p-value 0.024). 
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Given the SNPs explained ~0.04% of the variance of WBC count, with a sample size of 
188,074 at 80% power and 5% alpha, the study could detect an effect size of about 0.032. Given 
the SNPs explained ~0.02% of the variance of eosinophil and neutrophil counts, with sample 
sizes of 187,7580, at 80% power and 5% alpha the study could detect an effect size of about 
0.033.  
Associations with birth weight. Table 4.1 shows eosinophil count was inversely associated with 
birth weight using IVW and MR Egger estimates. Table 4.2 shows WBC count was associated 
with birth weight using weighted median and commix after excluding SNPS associated with 
confounders or thought to have pleiotropic effects. Neutrophil counts, IL6 and IL1ra were not 
associated with birth weight.  
 
Discussion 
This study suggests that an effect of eosinophil count or WBC count on infant birth 
weight cannot be excluded, but that neutrophil count, IL6, and IL1ra are not a cause of birth 
weight. This is in line with our hypothesis that an imbalance in leukocytes could lead to preterm 
labor and thus LBW. It is not surprising that eosinophils, but not neutrophils were causally 
related to LBW because some research suggests that eosinophils are a key marker of infection 
and can be found as the predominant cell in the amniotic fluid of women with preterm labor.80  
These findings may suggest that the relationship between stress and eosinophil cell counts is 
mediated by infection. Eosinophils are responsible for releasing cytokines to trigger an 
inflammatory response, and research suggests that preterm labor in the setting of infection results 
from the actions of proinflammatory cytokines secreted as part of the maternal host response to 
microbial invasion.80,211 This would support a theory proposed by Wahdwa et al. that maternal 
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stress may modulate characteristics of immunity to increase susceptibility to infection and 
thereby promote parturition through pro‐inflammatory mechanisms.40 And as we know preterm 
birth is highly correlated with LBW.212 Finally, IL6 and IL1ra are more markers of inflammation 
and auto-immunity than infection. Their lack of association with LBW along with the other 
findings is suggestive of infection playing more of a role.  
To the authors’ knowledge, this is the first MR study to explore the relationship between 
maternal immunity and birth weight. The results of this study provide a better understanding of 
the relation of the maternal immune-stress pathway with birth outcomes, knowledge that is 
currently lacking due to the dearth of existing studies that have been conducted on this subject. 
Chronic stress and stress hormones appear to be associated with immunosuppression and 
changes in the normal pattern of cellular and humoral responses to antigens.188 Thus, 
understanding how WBC count and eosinophil counts effect LBW may help us to better 
understand how stress is linked to LBW. This information may be valuable in preventing poor 
birth outcomes overall. Additionally, though this study included primarily white women of 
European descent, these findings may have transportability to non-white populations since 
causes are generally expected to act consistently135, particularly those with an understood 
biological mechanism. Immune systems do seem to vary by population, however, thus the 
association of eosinophil count and LBW should be tested in other groups. If stress-induced 
changes in WBC and eosinophil count cause LBW, then these findings might have particular 
relevance for populations experiencing extreme stress. For example, Black women in the US are 
more exposed or more susceptible to general and pregnancy-related stress than non-Hispanic 
White women, and may additionally face stress due to experience of racial prejudice and 
discrimination.4,33,34,35,142 Future research should focus on these causal relationships specifically 
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among this subset of women – though currently there are no large GWAS including this 
population. 
Causal knowledge of the effects of maternal immunity on fetal growth and development 
might pave the way for clinical guidelines during pregnancy. Multiple RCTs how shown that 
behavioral interventions during pregnancy can reduce stress.24,25,26,27,27,29,30 These interventions 
may, in turn, affect WBC or eosinophil counts and improve birth outcomes. Prenatal care which 
may detect and treat infections might also prevent immune response and have a positive impact. 
Finally, interventions which have shown to effectively treat conditions such as asthma by 
depleting eosinophils might be effective in preventing preterm birth and LBW and should be 
studied further.213 
MR studies have the advantage of providing unconfounded estimates, re-using existing 
resources and providing estimates even when no study including comprehensive information on 
exposure and outcome exists. We also used genetic associations with birth weight controlled for 
offspring genetics, eliminating the possibility that the association of maternal genetics with birth 
weight was acting through offspring genetics.  
An MR study, however, is limited by three underlying assumptions. First, the relevance 
assumption, which assumes each instrument strongly predicts each exposure. The average F-
statistics were over 70, when a value greater than 10 is taken as adequate strength.161 Second, the 
independence assumption, no confounders of genetic predictors on outcome should exist. Using 
Phenoscanner, we identified and eliminated any SNPs associated with potential confounders, 
including based on confounders that have been controlled for in the existing observational 
literature, i.e., BMI, weight, height, overall health status, and alcohol consumption. Lastly, the 
exclusion-restriction assumption - genetic instruments should only affect birth weight via 
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affecting the exposure. To assess for potential horizontal pleiotropy, where a genetic variant 
influences the outcomes through an independent pathway, Phenoscanner was used to identify 
direct associations of any of the SNPs for WBC count, eosinophil count, or neutrophil count with 
birth weight, or factors that might affect birth weight. Analysis was conducted with and without 
these SNPs. Finally, although less commonly stated, MR assumes that the association of SNPs 
with exposure and outcome are free from selection bias, particularly bias arising from the 
recruiting participants who have survived the exposure and competing risk of the outcome.163 
The GWAS of exposures and birth weight were conducted in relatively young people, however, 
among women who know they are pregnant, the miscarriage rate is thought to be between 10% 
to 20%.180 Conceptions of smaller infants miscarried due to maternal stress would bias the 
estimates towards the null. Miscarriage rates vary by race in the US, with black women more 
likely to experience a spontaneous abortion.214  
  Bias from population stratification, differences in allele frequencies between 
subpopulations as a result of non-random mating between individuals, is unlikely because the 
underlying studies included samples largely from people of European descent with genomic 
control. Canalization, or the ability of a population to produce the same phenotype regardless of 
variability of its genotype, is also possible.181 However, the extent to which it occurs, if any is 
unknown.  
 There are some additional limitations to this study. First, these instruments used in this 
study have not been replicated, so we used asthma and rheumatoid arthritis, which are known to 
be associated with WBC count, as control outcomes and found that both were significantly 
associated with WBC count. Positive controls were not tested for the remaining exposures. 
Second, we have assumed that genetic variants identified in these large GWAS of our exposures 
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variables in non-pregnant women are similarly associated in pregnant women. Third, we have 
assumed that the critical period of exposure to maternal indirect genetic effects is pregnancy, and 
that the estimates do not reflect pre-pregnancy effects on primordial oocytes or post-natal 
effects.182 Fourth, despite large sample sizes, as any other instrumental variable approach, this 
MR study suffers from limited statistical power. Fifth, a practical difficulty of determining which 
variants to include in a MR analysis is that of multiple testing. Though we could have used a 
Bonferroni-corrected p-value threshold to take into account the number of comparisons made, 
we opted not to because an approach that adjusts for multiple comparisons may lead to a lack of 
power to detect any specific association. Additionally, as several genetic variants may be 
correlated, a simple Bonferroni correction may be an over-correction.122 Finally, this study is 
limited in that it does not consider non-stress related drivers of eosinophil or WBC count, such as 




We found maternal immunity, specifically WBC count and eosinophil count, may affect birth 
weight. More investigation is required into the role of the maternal immuno-stress pathway in 
preventing LBW, a leading cause of morbidity and mortality among infants, particularly infants 
of color. In the meantime, based on existing intervention research and the findings of our study, 
clinicians should consider implementing comprehensive prenatal care programs that manage 




Table 4.1. Mendelian randomization estimates for associations of maternal WBC count 























0.720  425.5(<.001) 
Weighted median 0.034  -0.009, 
0.077 
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MR-Egger 0.021  -0.070, 
0.112 
0.649 0.513  








.012  370.6 (<.001) 
Weighted median -0.034  -0.085, -
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MR-Egger -0.163 -0.269, -
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0.399  381.6(<.001) 
Weighted median -0.020 -0.065, 
0.024 
0.366   
MR-Egger 0.010  -0.096, 
0.076 
0.827 0.870  
Conmix -0.01 -0.09, 0.05 .823   
IL6 (1 SNP) Inverse variance weighted 
0.064 -0.066, 
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Table 4.2. Mendelian randomization estimates for associations of maternal WBC count 
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MR-Egger 0.008 -0.069, 0.084 0.84
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Chapter 5: Discussion 
Summary 
Stress response disrupts regulation of systems throughout the body, including the 
neuroendocrine, cardiovascular, and immune systems.37 A growing body of research, largely 
driven by Dr. Pathik Wadhwa, has built support for neuroendocrine, immune, and vascular 
mechanisms of low birth weight (LBW).40,41 However, by Dr. Pathik’s own admission, very little 
empirical research to date has examined the role of biological processes as mediators of the 
relationship of stress with low birth weight.40 This study addresses this gap in the literature. 
These Mendelian randomization (MR) studies have shown that among the maternal stress 
biomarkers in question, cortisol, systolic BP, WBC count and eosinophil count are possible 
causes of birth weight. My findings generally support extant literature. My findings on cortisol 
are consistent with previous observational studies, which concluded that increased maternal 
cortisol levels are associated with restricted intrauterine growth and lower fetal weight.42-45  The 
findings, however, contradict another observational study that found maternal cortisol levels 
were negatively related to offspring birth weight but that this association was not significant after 
adjustment for gestational age at birth, infant sex, ethnicity, maternal age, parity, body mass 
index (BMI), and smoking.45 However, the validity of adjusting birth weight for gestational age 
is questionable. The internal validity of these observational studies may also be threatened by 
residual confounding and may thus produce biased findings. Unbiased estimates may be derived 
from experimental or quasi-experimental studies but, to my knowledge, there have been no such 
studies on this topic, making my study the first of its kind. 
My finding that systolic BP may affect infant birth weight is in line with the existing MR 
studies on this topic, which found maternal systolic BP reduced birth weight.71-73 The study fills a 
current gap in the quasi-experimental literature by 1) using sex-specific genetically instrumented 
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BP and adjusting for offspring genetics 2) implementing a multivariable MR analysis in order to 
assess independent effects of several vascular attributes (e.g., diastolic BP, systolic BP) and 3) 
using a positive control outcome to validate the instrument selection.71-73 Unlike Warrington et 
al. 72, who found a causal relationship of systolic BP with LBW, I also did not adjust for BMI in 
the selection of our instruments as doing so may lead to the exclusion of BMI related phenotypes 
and may bias the genetic estimates for blood pressure if common causes of BMI and blood 
pressure exist,117 as they undoubtedly do. The fact that we obtained a similar result despite not 
controlling for this covariate suggests that we cannot exclude an effect of systolic BP on birth 
weight. 
Little work has been done to look at the immune pathway in LBW, so few similar studies 
exist. Nevertheless, the conclusion that WBC count and eosinophil count may cause birth weight 
is in line with our hypothesis that an imbalance in immune cells, indicating immune response, 
could lead to LBW. The results of this study provide a better understanding of the relation of the 
maternal immune-stress pathway with birth outcomes, knowledge that is currently lacking due to 
the dearth of existing studies that have been conducted on this subject.  
 
Cortisol 
Within the neuroendocrine system, corticotropin stimulates secretion of cortisol by the 
adrenal cortex in response to stressors. Elevated cortisol inhibits release of corticotropin by the 
anterior pituitary gland and inhibits release of corticotrophin releasing hormone (CRH) by the 
hypothalamus. Chronic emotional or physical stress can interrupt this negative feedback loop, 
resulting in an overproduction of cortisol46 - making cortisol a good metric for measuring stress. 
Maternal stress has been shown to be associated with increases in placental, decidual, and 
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amniochorionic expression of CRH.40 In vivo studies have found significant correlations among 
maternal pituitary–adrenal stress hormones such as cortisol and placental CRH levels.47-50 CRH 
acts directly on the uterus and cervix and interacts with both prostaglandins and oxytocin, the 
two major uterotonics that mediate the stimulation and maintenance of myometrial contractility 
at term and during labor.51 Thus it seems logical that the potential mechanism may be that stress 
leads to elevated cortisol levels, which cause unregulated CRH levels, and in turn LBW. 
These findings are biologically plausible as there is evidence from human and animal 
models that cortisol crosses the placenta from the mother to the fetus.164 It has also been found 
that despite the effects of placental 11β hydroxysteroid dehydrogenase type 2, which deactivates 
cortisol, trans-placental transfer of cortisol is sufficient to affect fetal growth and physiology.165 
Analogous studies in sheep concluded that hydrocortisone infusion, the name for cortisol in 
medication form, during pregnancy in sheep affects fetal growth.166 Additionally, exposure to 
antenatal dexamethasone treatment, a steroid similar to cortisol prescribed to promote fetal lung 
maturation results in decreased birth weight adjusted for gestational age.167 
 
Systolic BP 
Fetal growth is dictated by placental function, with the placenta serving the critical 
respiratory, hepatic and renal functions of the fetus.215 Reduced utero-placental function has been 
suggested as one possible mechanism through which systolic BP might cause low birth weight 
because this has been found to occur in women with concurrent pre-eclampsia and fetal growth 
restriction.215  
 
WBC count and Eosinophils 
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Preterm birth is highly correlated with LBW.212 In fact,  the primary cause of low birth 
weight is preterm birth.18 White blood cells participate in the maintenance of pregnancy and 
alteration in their function or abundance may lead to labor at term or preterm.78 Microbial 
colonization and inflammation in the maternal genital tract has emerged as a major risk factor for 
spontaneous preterm birth and thus is relevant to the discussion of the etiology of LBW.77 
Eosinophil infiltration of the uteroplacental tissues and amniotic fluid have been have been 
associated with preterm labor79-81 and the most prevalent lower genital tract infection in women 
of reproductive age, bacterial vaginosis (BV), is associated with a higher risk of LBW.82-84 
Eosinophils are responsible for releasing cytokines to trigger an inflammatory response, and 
research suggests that preterm labor in the setting of infection results from the actions of 
proinflammatory cytokines secreted as part of the maternal host response to microbial 
invasion.80,211 This would support a theory proposed by Wahdwa et al. that maternal stress may 
modulate characteristics of immunity to increase susceptibility to infection and thereby promote 
parturition through pro‐inflammatory mechanisms.40  
 
Generalizability and transportability 
The results of these three studies in conjunction add to our understanding of the relation 
of the maternal stress pathway with birth outcomes, knowledge that is currently lacking due to 
the dearth of existing studies that have been conducted on this subject and the limitations of the 
existing studies. Understanding the mechanism through which stress affects LBW may be 
valuable in preventing poor birth outcomes overall. Additionally, though these studies included 
primarily white women of European descent, these findings may have transportability to non-
white populations since most causes are expected to act consistently,135 particularly those with an 
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understood biological mechanism. Cortisol is not known to function differently among different 
subgroups. Immune systems do seem to vary by population, however, thus the association of 
eosinophil count and LBW should be tested in other groups. If stress-induced changes in cortisol 
levels or eosinophil count cause LBW, then these findings might have particular relevance for 
populations experiencing extreme stress.  
In this country, Black non-Hispanic (NH) women are more likely to give birth to low 
birth-weight infants than their white NH counterparts.21 Poverty, educational disadvantage, less 
opportunity for optimal health behaviors, and poor access to health care are important factors 
associated with adverse health outcomes,22 and experienced at a greater rate by Black NH 
women than non-Hispanic white American women.23 However, research suggests that while 
structural disadvantage might partially explain racial differences in birth outcomes, this disparity 
persists even when controlling for a series of social, economic, and behavioral factors, including 
income, maternal age, parity, marital status, smoking, alcohol use, and health insurance 
coverage.24-27 
Increasingly disparities in birth outcomes are seen as rooted in racism.27,216-222 Structural 
racism in health care and social service delivery means that Black women often receive poorer 
quality care than white women.28,29 Additionally, it is well understood that the cumulative 
experience of racism triggers a chain of biological stress processes, known as weathering, that 
undermine Black women’s physical and mental health.30 Numerous case-control and cohort 
studies have demonstrated an association of exposure to general and pregnancy related stress 
with LBW.5-7,31,32 Furthermore, studies have shown that pregnant women of color in the US 
experience greater levels of stress overall, as well as additional sources of stress due to 
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experiences of discrimination and racism.4,33-35 Consequently, the findings of these studies might 
help to explain the observed racial disparity in birth outcomes.  
Clinical Implications 
Causal knowledge of the effects of maternal stress on fetal growth and development 
might pave the way for clinical guidelines during pregnancy. Multiple RCTs how shown that 
behavioral interventions during pregnancy can reduce stress, though none of these studies have 
assessed the effect on birth weight.145-151 These interventions may, in turn, affect cortisol levels, 
systolic BP, WBC count or eosinophil counts and improve birth outcomes. Some preliminary 
research suggests that chemical interventions may be successful in reducing cortisol levels 168-170 
and BP.175 Additionally, prenatal care which may detect and treat infections might also prevent 
immune response and have a positive impact, though both the underlying cause of an treatment 
for bacterial vaginosis are but not completely understood.223 Interventions which have shown to 
effectively treat conditions such as asthma by depleting eosinophils might be effective in 
preventing preterm birth and LBW and should be studied further.213 Finally, further 
consideration should be given to social and environmental determinants that might improve birth 
outcomes, such as improving living conditions to reduce risk of infectious disease.224 
 
Strengths and limitations 
MR studies have the advantage of providing unconfounded estimates, re-using existing 
resources and providing estimates of association even when no study including comprehensive 
information on both exposure and outcome exists. We also used genetic associations with birth 
weight controlled for offspring genetics, eliminating the possibility that the association of 
maternal genetics with birth weight was acting through offspring genetics. In using MR these 
studies fill meaningful gaps in the existing literature on this subject. 
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An MR study, however, is limited by three underlying assumptions. First, the relevance 
assumption, which assumes each instrument strongly predicts each exposure. The average F-
statistics were over 70, when a value greater than 10 is taken as adequate strength.161 I also 
attempted to use SNPs of known phenotype when possible (aim 1) or to validate my instrument 
selection through the use of a positive control (aims 2 and 3). Second, the independence 
assumption, no confounders of genetic predictors on outcome should exist. Using Phenoscanner, 
we identified and eliminated any SNPs associated with potential confounders based on 
confounders that have been controlled for in the existing observational literature, including BMI, 
weight, height, overall health status, and alcohol consumption. Lastly, the exclusion-restriction 
assumption - genetic instruments should only affect birth weight via affecting the exposure, 
which excludes selection bias for instrument on outcome. To assess for potential horizontal 
pleiotropy, where a genetic variant influences the outcomes through an independent pathway, 
Phenoscanner was used to identify direct associations of any of the SNPs for cortisol, BP, WBC 
count, eosinophil count, or neutrophil count with birth weight, or factors that might affect birth 
weight. Analysis was conducted with and without these SNPs. Finally, although less commonly 
stated, MR assumes that the association of SNPs with exposure and outcome are free from 
selection bias, particularly bias arising from the recruiting participants who have survived the 
exposure and competing risk of the outcome.163 The GWAS of exposures and birth weight were 
conducted in relatively young people, however, among women who know they are pregnant, the 
miscarriage rate is thought to be between 10% to 20%.180 Conceptions of smaller infants 
miscarried due to maternal stress would bias the estimates towards the null. Miscarriage rates 
vary by race in the US, with black women more likely to experience a spontaneous abortion.214 
There is also a possibility some smaller babies who would have been LBW did not survive to 
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live birth because of maternal stress which would attenuate the relation of maternal stress with 
LBW. 
Bias from population stratification, differences in allele frequencies between 
subpopulations as a result of non-random mating between individuals, is unlikely because the 
underlying studies included samples largely from people of European descent with genomic 
control. Canalization, or the ability of a population to produce the same phenotype regardless of 
variability of its genotype, is also possible.181 However, the extent to which it occurs, if any is 
unknown.  
There are some additional limitations to this dissertation. First, some of the instruments 
used in these studies have not been replicated. Second, we have assumed that genetic variants 
identified in these large GWAS of our exposure variables in non-pregnant women are similarly 
associated in pregnant women. Third, we have assumed that the critical period of exposure to 
maternal effects is pregnancy, and that the estimates do not reflect pre-pregnancy effects on 
primordial oocytes or post-natal effects.182 Fourth, despite large sample sizes, as any other 
instrumental variable approach, these MR studies suffer from limited statistical power. Finally, 
due to data availability, the study contains only participants of European descent who may not 
even be mothers. Genetic studies that include many Americans or that can be subsetted to a black 
population either do not exist or are not sex-specific.   
 
 
Conclusion and Suggestion for Further Research 
I found that the maternal cortisol levels, systolic BP, WBC count, and eosinophil count 
may lower birth weight. More investigation is required into the role of the maternal stress 
pathway in preventing LBW, a leading cause of morbidity and mortality among infants, 
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particularly infants of color. In order to generate additional support for our findings, further 
research should focus on creating GWAS that are more inclusive of and/or specific to our 
primary populations of interest, such as Black individuals and pregnant women. Then similar 
MR studies could be replicated to triangulate our conclusions. Mediation analysis should also be 
conducted to understand the possible link between stress, infection, eosinophil count, and LBW. 
Additionally, future research should consider exploring how each of the stress pathways might 
work in concert to effect LBW. In the meantime, based on existing intervention research and the 
findings of our study, clinicians should consider implementing comprehensive prenatal care 




• Mendelian randomization can determine causal associations between exposures and 
outcomes, if appropriate instruments are identified and adequate sample sizes are 
available.  
• These MR studies showed that cortisol levels (a neuroendocrine marker), systolic BP (a 
vascular marker), and WBC count and eosinophil count (immune markers) could cause 
LBW. 
• Further research should be conducted to explore how the neuroendocrine, vascular, and 
immune stress pathways might work in concert to affect LBW. 
• Additional GWAS including Black individuals and/or pregnant women would be 




Appendix 1: R Code 
 






#for MR PRESSO 












#reformat the RSID variable so it will match with the exposures aka trim white space 
cols_to_be_rectified <- names(BW)[vapply(BW, is.character, logical(1))] 
BW[,cols_to_be_rectified] <- lapply(BW[,cols_to_be_rectified], trimws) 
 
 




##eliminate all SNPs expect for those used by Crawford et al. 
cortisol <- subset(cortisol, rs_number %in% c("rs12589136", "rs2749527", "rs11621961")) 
 
#extract the SNPs I plan to use from outcome dataset 
BW1 <- subset(BW, RSID %in% c("rs12589136", "rs2749527", "rs11621961")) 
 
library(tidyverse) 
BW1 <- rename(BW1, beta.outcome = beta) 
BW1 <-rename(BW1, se.outcome = se) 
BW1 <-rename(BW1, effect_allele.outcome = ea) 
BW1 <-rename(BW1, other_allele.outcome = nea) 
BW1 <-rename(BW1, eaf.outcome = eaf) 
cortisol<- rename(cortisol, beta.exposure = beta) 
cortisol<- rename(cortisol, se.exposure = se) 
cortisol <- rename (cortisol, effect_allele.exposure = reference_allele) 
cortisol <- rename (cortisol, other_allele.exposure = other_allele) 
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cortisol <- rename (cortisol, eaf.exposure = eaf) 
 
# merge exposure and outcome 
SA1 <- merge (cortisol, BW1, by.x ='rs_number', by.y = 'RSID', all.x = TRUE ) 
 
# visual check on allele alignment and pallindromic SNPs (A/T or C/G) that must match on EAF 
as well 
check<-data.frame(SA1$effect_allele.exposure,SA1$other_allele.exposure,SA1$eaf.exposure, 
                  SA1$effect_allele.outcome,SA1$other_allele.outcome,SA1$eaf.outcome) 
check 
#check was succesful - alligned the same way 
 
 
# Calculate total F-statistic for all SNPs assuming standardized co-efficients 













#make correlation matrix for three SNPs 
snps<-c("rs11621961", "rs12589136", "rs2749527") 
library(TwoSampleMR) 
matrix<-ld_matrix(snps, with_alleles = TRUE, pop = "EUR") 
 
#need to rewrite this because the ld_matrix flipped one of the signs 
matrix1 <- matrix(c(1.000000, -0.233301, 0.437229, -0.233301, 1.000000, 0.491219, 0.437229, 
0.491219, 1.000000), nrow = 3, ncol = 3,byrow = TRUE, 
                ) 
matrix1 
 
#put data into format for MendelRandomization 
MRprep<-data.frame(bx=SA1$beta.exposure, 
                   bxse=SA1$se.exposure, 
                   by=SA1$beta.outcome, 
                   byse=SA1$se.outcome, 
                   exposure="cortisol", 
                   outcome="LBW", 
                   snps=SA1$rs_number) 
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Speicifc Aim 2:  
 





#read in variants file from ben neale lab 







sl<-variants[variants$rsid %in% ifl$RSID,] #find the variant number for the relevant SNPs 
bennm <- SBP 
sll<-bennm[bennm$variant %in% sl$variant, ] #look up the variant in the UKBB data file 
benna<-merge(sl,sll,by="variant") #merge together variants info and exposure data info  
 
vkf<-benna[benna$pval<0.00000005,] #select pvalue<5x10-8 
nrow(vkf) 
write.csv(vkf,"/Users/madelinetravers/Desktop/CUNY/Dissertation/data/vkf.csv", row.names = 
FALSE) 
vk1<-vkf[!is.na(vkf$rsid),] #fixes clump issue when 0 snps are returned  
 
#vkf[1,] 
#put data into format for MRbase 
vta<-data.frame(SNP = vk1$rsid, 
                beta.exposure = vk1$beta, 
                se.exposure = vk1$se, 
                effect_allele.exposure = vk1$ref, 
                other_allele.exposure =vk1$alt, 
                pval.exposure = vk1$pval, 
                eaf.exposure = vk1$AF, 








# Calculate total F-statistic for all SNPs assuming standardized co-efficients 


















#throw out SNPs we think might be associated with confounders or pleiotropic 
comb5<-subset(comb5, SNP !="rs10193706"   
      & SNP != "rs11065898"  
      & SNP != "rs117539635"  
      & SNP != "rs1229984"  
      & SNP != "rs12416331" 
      & SNP != "rs1290790"  
      & SNP != "rs1476781"  
      & SNP != "rs16930710"  
      & SNP != "rs16992771"  
      & SNP != "rs17011002"  
      & SNP != "rs2161356"  
      & SNP != "rs2193950"  
      & SNP != "rs2240980"  
      & SNP != "rs2274224"  
      & SNP != "rs2303083"  
      & SNP != "rs35021474"  
      & SNP != "rs35085068"  
      & SNP != "rs42038"  
      & SNP != "rs4768882"  
      & SNP != "rs4932373"  
      & SNP != "rs4986172"  
      & SNP != "rs507506"  
      & SNP != "rs557462"  
      & SNP != "rs55857306"  
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      & SNP != "rs56013326"  
      & SNP != "rs58452693"  
      & SNP != "rs6449"  
      & SNP != "rs6456469"  
      & SNP != "rs68054037"  
      & SNP != "rs6919225" 
      & SNP != "rs6923947" 
      & SNP != "rs7107356" 
      & SNP != "rs72995085" 
      & SNP != "rs73026246" 
      & SNP != "rs73046792" 
      & SNP != "rs752268" 
      & SNP != "rs78862806" 
      & SNP != "rs79098424" 
      & SNP != "rs908671" 
      & SNP != "rs9636202") 
 






#change sign of one beta if effect alleles do not match 





comb5$swap <- -1.0  
data.frame(comb5$nea,comb5$effect_allele.exposure, comb5$swap)[1:4,] #check alignment 
comb5$beta.exposure<-comb5$beta.exposure*comb5$swap #reverse beta for exposure if effect 






                   bxse=comb5$se.exposure, 
                   by=comb5$beta, 
                   byse=comb5$se, 
                   exposure="DBP", 
                   outcome="BW", 
                   snps=comb5$SNP) 
write.table(MRprep, "MRprepSBP.txt") 
detach(package:TwoSampleMR, unload = TRUE) 
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Specific aim 3: 





#read in variants file from ben neale lab 







sl<-variants[variants$rsid %in% ifl$RSID,] #find the variant number for the relevant SNPs 
bennm <- WBC 
sll<-bennm[bennm$variant %in% sl$variant, ] #look up the variant in the UKBB data file 
benna<-merge(sl,sll,by="variant") #merge together variants info and exposure data info  
 
vkf<-benna[benna$pval<0.00000005,] #select pvalue<5x10-8 
nrow(vkf) 
vk1<-vkf[!is.na(vkf$rsid),] #fixes clump issue when 0 snps are returned  
 
#vkf[1,] 
#put data into format for MRbase 
vta<-data.frame(SNP = vk1$rsid, 
                beta.exposure = vk1$beta, 
                se.exposure = vk1$se, 
                effect_allele.exposure = vk1$ref, 
                other_allele.exposure =vk1$alt, 
                pval.exposure = vk1$pval, 
                eaf.exposure = vk1$AF, 







# Calculate total F-statistic for all SNPs assuming standardized co-efficients (=77.5) 
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vtas$r2<-2*vtas$eaf.exposure * (1-vtas$eaf.exposure) * (vtas$beta.exposure) * 
(vtas$beta.exposure) 
















#throw out SNPs we think might be associated with confounders or pleiotropic 
comb5<-subset(comb5, SNP !="rs10822168"   
              & SNP != "rs3184504"  
              & SNP != "rs2445754"  
              & SNP != "rs12941356"  
              & SNP != "rs11650692" 
              & SNP != "rs8108722"  
              & SNP != "rs1260326"  
              & SNP != "rs9876650"  
              & SNP != "rs337637"  
              & SNP != "rs723585"  
              & SNP != "rs7143806"  
              & SNP != "rs2476601"  
              & SNP != "rs2925979"  
              & SNP != "rs12755338"  
              & SNP != "rs2303083"  
              & SNP != "rs2807742"  
              & SNP != "rs1631174"  
              & SNP != "rs174548"  
              & SNP != "rs1151512"  
              & SNP != "rs1362965"  
              & SNP != "rs1975371"  
              & SNP != "rs28621809"  
              & SNP != "rs12453682"  
              & SNP != "rs851612"  
              & SNP != "rs1047891"  
              & SNP != "rs7578666"  
              & SNP != "rs139419"  
 93 
              & SNP != "rs7684253" 
              & SNP != "rs2631367"  
              & SNP != "rs72796106" 
              & SNP != "rs566465" 
              & SNP != "rs12363256" 
              & SNP != "rs8044524" 
              & SNP != "rs11150589") 
               






#change sign of one beta if effect alleles do not match 





comb5$swap <- -1.0  
data.frame(comb5$nea,comb5$effect_allele.exposure, comb5$swap)[1:4,] #check alignment 
comb5$beta.exposure<-comb5$beta.exposure*comb5$swap #reverse beta for exposure if effect 






                   bxse=comb5$se.exposure, 
                   by=comb5$beta, 
                   byse=comb5$se, 
                   exposure="DBP", 
                   outcome="BW", 
                   snps=comb5$SNP) 
write.table(MRprep, "MRprepWBC.txt") 
detach(package:TwoSampleMR, unload = TRUE) 
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